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Abstract
Regional anaesthetic techniques for the management of post-operative pain
following total knee arthroplasty (TKA) are becoming increasingly popular. The purpose
of this randomized control trial was to assess whether periarticular infiltration and
infusion (LIA and infusion) had a comparable time-to-discharge and analgesic quality to
a motor-sparing nerve block (MSNB) technique in patients who have undergone TKA.
The study arms included continuous MSNB (n=35, control) and LIA and infusion (n=35,
experimental). Continuous anaesthetic infusion of 0.2% Ropivacaine was delivered at a
rate of 8ml/hr post-operatively. The primary outcome was time to discharge. Secondary
objectives included pain scores at rest and activity, narcotic consumption, patient
satisfaction and functional outcomes. Preliminary analysis of 54 patients (MSNB n=29,
LIA and infusion n=25) was performed. No significant differences in outcome measures
were demonstrated between groups. Based on these early findings, LIA and infusion
provides similar clinical and functional outcomes to MSNB following primary TKA.

Keywords
Total knee arthroplasty, primary, motor-sparing nerve block, periarticular infiltration,
wound infusion, continuous regional anaesthesia
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Lay Summary
Total knee replacement continues to become a more common surgical treatment
option for knee arthritis in the Canadian population. Following surgery, a common
complaint from patients is pain, which can inhibit their ability to mobilise early and delay
discharge from hospital. Many pain options for pain control are available, each
possessing their own benefits, but also potential risks. One promising option has been
the use of local anaesthetic delivered around a nerve or the surgical site to decrease
pain peripherally. This randomised trail assessed two pain control options using local
anaesthetic that was constantly delivered either around a nerve or the surgical site to
prolong the duration of pain control. These two groups were a motor-sparing nerve
block (control group) and a novel periarticular infusion system (experimental group) that
was placed in the tissue surrounding the knee joint. We compared the time to
discharge, pain scores during rest and activity, narcotic medication consumption, and
patient reported outcomes to assess if our experimental group produced similar
outcomes to a proven peripheral nerve block following total knee arthroplasty. This
study’s purpose was to explore a continuous regional anaesthetic technique that was
provided by a surgeon to circumvent factors such as resource constraints that prohibit
the widespread use of peripheral nerve blocks in community centres for pain control
following total knee replacement.
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Chapter 1

1

Introduction

The societal demand for total knee arthroplasty (TKA) in Canada is increasing as the
population ages and average body mass index (BMI) grows, increasing from 55,501
cases in 2012 to 64,204 in 20161–4. Though TKA has positive long-term functional
outcomes and improved quality of life, the post-surgical pain associated with the
procedure can affect patient’s ability to perform physiotherapy effectively and negatively
affect their post-operative satisfaction5,6. Pain is one of the most common post-operative
complaints from patients and as it is a subjective experience, it can be challenging to
anticipate and manage in the early post-operative period. Care-teams regularly rely on
narcotic analgesics delivered through oral or intravenous patient-controlled analgesia
(PCA) to reduce patients’ pain, and though these are effective analgesic options, they
have an undesirable side-effect profile7. These unwanted secondary effects are well
documented, and range from nausea, sedation, pruritus, and constipation to more
severe complications like addiction, respiratory depression, and death8. As a result,
regional analgesic modalities have continued to pique the interest of the surgical
community as effective alternatives to opioid-based management options. These
include continuous epidural analgesia (CEA), femoral nerve blocks (FNB) and adductor
canal block (ACB)/motor-sparing nerve block (MSNB), which have all been found to be
effective in managing patient’s immediate post-operative pain9–12. They also provide the
option to deliver anaesthetic agents continuously for a longer analgesic duration, but
each comes with varying adverse effects and logistical issues. CEA and FNB can cause
quadriceps weakness and thus delay early mobilization, patient discharge, and increase
the risk of inpatient falls1013. Motor sparing nerve blocks are increasing in popularity as
they reduce the impact of most of these issues, but are expensive and require
dedicated staff and resources, making it a challenge to implement as a standard care
option in Canadian hospitals14–16.
Another method that has been adopted in arthroplasty is the use of periarticular
infiltration analgesia, where local anaesthetic is injected around the joint and incision to
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provide thorough anaesthetic coverage12,17. Periarticular infiltration reduces the risk of a
dense motor blockade following surgery and the resources required to provide regional
blocks12,18,19. It also provides an analgesic quality comparable to that of regional blocks
following TKA, but does not come without its own compromises19–21. A significant issue
with periarticular infiltration is the inability to continuously deliver local anaesthetic after
closure of the surgical incision. A previous study conducted in our center found that
periarticular infiltration had a shorter analgesic duration compared to that of single-shot
MSNB technique 12. Without continuous infusion, increased narcotic consumption,
inability to perform physiotherapy, and an increase in length of stay can occur after the
duration of effective analgesia has passed.
We explored the application of periarticular infiltration and infusion, a regional
anaesthetic method that allows for the continuous delivery of local anaesthetic following
wound infiltration and closure. A feasible regional technique following TKA needs to
manage pain to reduce narcotic consumption, be accessible to care providers, is costeffective, and not inhibit patients’ ability to ambulate so as to expedite discharge and
reduce hospital resource utilization. By investigating time to discharge, pain, narcotic
consumption, physiotherapy progress, and functional outcomes, we intend to determine
if periarticular infiltration and continuous wound infusion is an effective regional
anaesthetic alternative and is comparable in terms of analgesic quality and outcomes to
our previously explored MSNB technique.
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Chapter 2

2

Anatomy

2.1 Anatomy of the Thigh
2.1.1

Osteology
The femur makes up the skeletal structure in the thigh of the lower limb and is

both the strongest and longest bone in the human body. It is part of the appendicular
skeleton and articulates proximally with the acetabulum of the pelvis through the hip
joint, a ball and socket type joint. Distally, the femur articulates with the proximal
tibia through a modified hinge type joint called the tibiofemoral joint, as well as the
patella through a gliding joint called the patellofemoral joint. Together, these create the
knee joint. 22
The structure of the femur is unique to suit its function as an essential load bearing
structure and serves as the origin and insertion for 23 different muscles (figure 1).
Proximally the major structures include the femoral head, neck, greater trochanter,
lesser trochanter, intertrochanteric line, and gluteal tuberosity. The femoral head is a
spheroidal structure that is oriented in an anterosuperiomedial direction off the femoral
neck. Its smooth surface is only interrupted posteroinferiorly by the fovea, a roughened
structure that allows for the insertion of the ligamentum teres. It is covered in articular
cartilage and articulates with the acetabulum to create the hip joint. The femoral neck
projects from the femur at an average neck-shaft angle of 135 degrees, with an
anteversion angle of 15-20 degrees. At its base is where the greater and lesser
trochanters can be found. The greater trochanter is found posterolateral and serves as
the attachment for multiple muscle groups. Gluteus minimus and gluteus medius insert
at the greater trochanter to provide the action of hip abduction. The lesser trochanter
can be found posteroinferiorly at the junction of the femoral shaft and the base of the
femoral neck and serves as the tendinous insertion point for the iliacus and psoas
muscles responsible for hip flexion. The intertrochanteric line is a ridge of bone found
anteriorly on the femur at the junction of the femoral neck and shaft. Structures that
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attach to it include the lateral border of the hip joint capsule as well as the iliofemoral
ligament. 22
The diaphysis of the femur is the long, cylindrical shaped portion and has an anterior
bow with a femoral radius of curvature ranging from 98-120cm in the
sagittal plane 23. The diaphysis extends distally at an oblique angle to allowing for
a weight bearing axis that travels through the centre of the femoral head, knee joint
and ultimately ankle joint. Posteriorly, along its shaft, runs a roughened line called the
linea aspera, which serves as the insertion point for medial compartment adductors as
well as the vastus medialis and lateralis, short head of biceps femoris and a portion of
the gluteus maximus at the gluteal tuberosity of the linea aspera. As the diaphysis
travels distally, the femoral shaft begins to flare and form the lateral and medial
condyles that articulate with the proximal tibia as well as the medial and lateral
epicondyles and adductor tubercle which serve as the attachment points for various
ligaments and tendons. Between the two condyles you will find the trochlear groove, a
smooth area that makes up the femoral portion of the patellofemoral joint.

Figure 1: Posterior (A.) and anterior (B.) femoral muscular attachments
Reprinted with permission by otaonline.org
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2.1.2

Muscular Compartments:

The thigh is divided into three osteofascial compartments, called the anterior, posterior
and medial compartments of the thigh. Two Intermuscular fascial septa extend from the
fascia lata, the tough deep fascia of the thigh, down to the bone forming the anterior and
posterior osteofascial compartments. The medial compartment is functionally
considered its own compartment, as it is not separated by a distinct fascial plane. Figure
2 demonstrates their various attachments and insertions. 22

2.1.2.1

Anterior Compartment:

The anterior compartment is most functionally involved with knee joint extension, but
also hip flexion. The muscles contained in the anterior compartment include sartorius,
rectus femoris, vastus medialis, vastus medialis obliquus, vastus lateralis, vastus
intermedius, and articularis genu. The muscles rectus femoris, vastus medialis, vastus
lateralis, and vastus intermedius are collectively referred to as quadriceps femoris22.
Table.1 provides information regarding origin, insertion, action, innervation, and
vascular supply for the anterior compartment muscles.
Table 1: Anterior compartment muscles
Muscle

Origin

Insertion

Action

Innervation

Vascular
Supply

Sartorius

Anterior Superior

Pes

Knee extension,

Femoral

Branches

Iliac Spine

Anserinus

hip flexion,

Nerve (L2-3)

from

Rectus

Anterior inferior

Quadriceps

Femoris

iliac Spine and

femoris

groove superior to

tendon->

acetabulum

patella

Vastus

Inferior aspect

Quadriceps

Medialis

Intertrochanteric

femoris

thigh abduction

Superficial

and internal

Femoral

rotation

Artery

Knee extension

Knee extension

Femoral

Artery of the

Nerve (L2-4)

Quadriceps

Femoral

Branches

Nerve (L2-4)

from

6
line, medial lip of

tendon->

Superficial

linea aspera,

patella

Femoral

medial

Artery

supracondylar
line, medial
intermuscular
septum
Vastus

Lowest fibres of

Quadriceps

Patellofemoral

Femoral

Artery of the

Medialis

Vastus Medialis

femoris

joint stability

Nerve (L2-4)

Quadriceps

Obliquus

(same intsertion)

tendon->
Knee extension

Femoral

Artery of the

Nerve (L2-4)

Quadriceps

Femoral

Artery of the

Nerve (L2-4)

Quadriceps

patella
Vastus

Superior aspect

Quadriceps

Lateralis

Intertrochanteric

femoris

line, anterior and

tendon->

inferior borders of

patella

greater trochanter,
lateral lip of gluteal
tuberosity, lateral
lip of linea aspera
Vastus

Anterior and

Quadriceps

Intermedius

lateral upper two-

femoris

thirds of femoral

tendon->

shaft, lateral

patella

Knee extension

intermuscular
septum
Articularius

Distal anterior

Proximal

Pulls

Femoral

Lateral

Genu

femoral shaft

reflection of

suprapatellar

Nerve (L2-4)

Femoral

knee joint

bursae during

Circumflex

synovium

knee extension

Artery

2.1.2.2

Medial Compartment:

The medial compartment is responsible for adduction across the hip joint, and thus the
lower leg. Some muscles have multiple compartments, having portions in the medial
compartment as well as the anterior or posterior compartments. These include adductor
magnus (medial and posterior compartments), adductor longus (medial and anterior
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compartments) and pectineus (medial and anterior compartments). Though the medial
compartment is not defined by intermuscular fascial septae, it is functionally considered
a separate osteofacial compartment22. Table 2 provides information regarding origin,
insertion, action, innervation, and vascular supply for the medial compartment muscles.
Table 2: Medial compartment muscles
Muscle

Origin

Insertion

Action

Innervation

Vascular
Supply

Pectineus

Pecten pubis

Lesser

Hip adduction

Femoral (L2-

Medial

trochanter

and flexion

3) nerve +/-

femoral

and linea

accessory

circumflex

aspera

obturator

artery

nerve (L3)
Gracilis

Inferior pubic

Pes

Hip

Obturator

Artery to the

ramus

anserinus

adduction,

nerve (L2-3)

adductors

Adductor

Pubic body,

Longus

Linea aspera

flexion and

branch of

medial

profunda

rotation

femoris

Hip adduction

Obturator

Artery to the

below pubic

and gait

nerve (L2-4)

adductors

crest

stabilization

branch of
profunda
femoris

Adductor

Inferior pubic

Lesser

Hip adduction

Obturator

Artery to the

Brevis

ramus

trochanter

and gait

nerve (L2-3)

adductors

and linea

stabilization

branch of

aspera

profunda
femoris

Adductor

Inferior pubic

Linea aspera

Hip adduction

Obturator

Branches of

Magnus

ramus,

and adductor

and gait

nerve and

the profunda,

ischial

tubercle

stabilization

sciatic nerve

obturator,

(L2-4)

and

ramus, and
ischial

superficial

tuberosity

femoral
arteries
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Within the medial compartment, a triangular shaped canal called the adductor canal is
formed by the borders of sartorius anteriorly, vastus medialis anterolaterally, and
posteromedially by adductor longus and magnus (figure 2). Commonly referred to as
the adductor canal, it is also known as Hunter’s canal or the sub-sartorial canal, and
contains the femoral artery and vein, descending genicular and muscular branches of
the femoral artery, the saphenous nerve, and the nerve to vastus medialis prior to its
insertion into the muscle. The adductor canal begins at the apex of where the medial
margins of sartorius and adductor longus meet. Two-thirds of the way down the canal
the femoral vessels pass posteriorly into the popliteal fossa through the adductor hiatus,
an tendinous opening in adductor magnus 2224.

Figure 2: The borders of the adductor canal
Reprinted with permission from teachmeanatomy.info

2.1.2.3

Posterior Compartment:

The posterior compartment of the thigh has the function of knee flexion and hip
extension and include the following muscles; biceps femoris, semitendinosus, and
semimembranosus. Collectively known as the hamstring muscles, they span across
both the knee and hip joints. At the knee, they form the proximal borders of the popliteal
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fossa, with the biceps femoris laterally and semimembranosus and semitendinosus
medially. Table 3 provides information regarding origin, insertion, action, innervation,
and vascular supply for the posterior compartment muscles
Table 3: Posterior compartment muscles
Muscle

Origin

Insertion

Action

Innervation

Vascular
Supply

Biceps Femoris

Semitendinosus

Long head-

Head of the

Hip

Sciatic nerve

Perforating

ischial

fibula,

extension,

(L5, S1-2)

branches of

tuberosity,

fibular

knee

profunda

sacrotuberous

collateral

flexion, and

femoris,

ligament

ligament,

lateral

medial

Short head-

and lateral

rotation of

lateral lip of

tibial

thigh

linea aspera

condyle

Ischial

Pes

Hip

Sciatic nerve

Perforating

tuberosity-

anserinus

extension

(L5, S1-2)

branches of

inferomedially
Semimembranosus

profunda

flexion

femoris

Ischial

Medial tibial

Hip

Sciatic nerve

Perforating

tuberosity-

condyle.

extension

(L5, S1-2)

branches of

superolaterally

2.1.3

and knee

and knee

profunda

flexion

femoris

Muscle and Cutaneous Innervation:

The lumbar and sacral plexuses are responsible for providing the lower limb both motor
and sensory functions through a number of nerve branches. The lumbar plexus leaves
the spinal canal at vertebral levels L1-L3 and travels deep within the psoas major
muscle, while the lumbosacral trunk (L4-L5) travels medial on the posterior abdominal
wall. The sacral plexus (S1-4) travels within the pelvis on the anterior surface of the
piriformis muscle and external to the pelvic fascia. Together, the lumbosacral trunk and
sacral plexus form the lumbosacral plexus. These collections of nerve roots form their
associated branches the more distal they move22. The primary segmental innervation
associated with various hip and knee movements can be found in table 4.

10

Table 4: Segmental innervation and principle nerve roots for hip and knee
movement
Movement

Muscle Group

Nerve

Root

Hip Flexion

Iliopsoas

Femoral Nerve

L1-2

Hip Extension

Gluteus maximus

Sciatic Nerve

L5-S1

Hip Abduction

Gluteus medius and

Superior Gluteal Nerve

L4-L5

minimus, Tensor Fasciae
Latae,
Hip Adduction

Adductors

Obturator Nerve

L2-3

Knee Flexion

Hamstring Muscles

Sciatic Nerve

S1

Knee Extension

Quadriceps femoris

Femoral Nerve

L3-4

2.1.3.1

Lateral Cutaneous Femoral Nerve (L2-3):

The lateral cutaneous femoral nerve arises at the spinal levels of L2-3. Its route to the
thigh begins at the lateral boarder of the psoas major muscle, crossing the iliacus
muscle and entering the leg medial to the anterior superior iliac spine either through or
posterior to the inguinal ligament. From there, the nerve will variably pass through or
behind sartorius where two branches arise, the anterior and posterior divisions. The
anterior supplies sensory innervation to the anterolateral thigh as far as the knee. The
posterior is responsible for the skin overlying the greater trochanter and may supply
some of the gluteal area22.

2.1.3.2

Femoral Nerve (L2-4):

The femoral nerve is primarily responsible for the anterior compartment of the thigh. It
provides motor innervation for muscles involved in knee extension and hip flexion as
well as cutaneous sensory branches. It is the largest branch of the lumbar plexus and
gives innervation to the iliacus and pectineus before dividing into the anterior and
posterior femoral nerve branches at the level of the lateral femoral circumflex artery.
The anterior division of the femoral nerve supplies the medial and intermediate
cutaneous nerves of the thigh (figure 3) as well as the nerve to sartorius. The posterior
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division contains the motor branches to quadriceps femoris (rectus femoris, vastus
medialis, vastus medialis obliquus, vastus lateralis, vastus intermedius) as well as the
largest and longest femoral nerve cutaneous branch, the saphenous nerve. The
saphenous nerve is responsible for sensation to the medial aspect of the knee as well
as the lower leg. It descends through the adductor canal and at the distal end gives off
an infrapatellar branch (contributes to the peripatellar plexus) providing sensation to the
anteromedial capsule, and patellar tendon. It then pierces the fascia lata between the
tendons of gracilis and sartorius and continues subcutaneously to supply the prepatellar
skin and medial lower leg, accompanying the long saphenous vein.

2.1.3.3

Obturator Nerve (L2-4):

The obturator nerve originates from the lumbar plexus at roots L2-4. It descends within
the psoas major muscle, passing behind the common iliac vessels, along the lateral wall
of the pelvis and to the obturator foremen. At the foremen, it divides into the anterior
and posterior branches, with the anterior providing motor function to adductor longus,
gracilis, and usually adductor brevis and pectineus as well. It also provides sensory
input from the hip joint as well as a cutaneous branch that contributes to the subsartorial
plexus, a network of sensory nerves for the medial aspect of the thigh. The posterior
branch provides adductor magnus with its motor input as well as adductor brevis (when
not supplied by the anterior branch). Its terminal branch is the genicular branch of the
obturator nerve, a sensory filament for the knee joint capsule within the popliteal fossa.

2.1.3.4

Sciatic Nerve (L4-5, S1-3):

The sciatic nerve is the thickest nerve in the body and has plexus contributions from
both the lumbosacral trunks (L4-L5) and sacral plexus (S1-3). It exits the pelvis through
the greater sciatic foramen, below the piriformis muscle, and descends distally deep to
gluteus maximus along the posterior aspect of the thigh. Along its path, it provides
sensory branches to the posterior capsule of the hip joint, as well as motor branches to
the biceps femoris, semitendinosus, semimembranosus, and the ischial origin of
adductor magnus. Proximal to the knee, it branches into its two largest components, the
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tibial and common peroneal nerves. Though the level of division is highly variable, it is
typically described to occur at the junction of the middle and distal thirds of the thigh.
The tibial nerve is responsible for innervating the deep and superficial posterior
compartments of the lower leg, and the common peroneal nerve innervates the lateral
and anterior compartments through its superficial and deep branches respectively22.

2.1.3.5

Posterior Cutaneous Nerve of the Thigh (S1-3):

The posterior cutaneous nerve stems from the sacral nerve roots S1-3 and leaves the
pelvis through the greater sciatic foremen. It travels distally beneath the fascia lata in
the thigh and superficial to the long head of biceps femoris, providing sensory input from
the gluteal, perineum, and posterior thigh and knee.

A.

B.

C.

Figure 3: The nerves (A.), cutaneous branches (B.) and segmental cutaneous
distribution (C.) of the lower limb
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Reprinted with permission from theodora.com/anatomy

2.2

Arterial Blood Supply:

The blood supply for the thigh is provided by the femoral artery and its associated
branches. The femoral artery is a branch of the external iliac artery, and begins at the
mid-inguinal point, an anatomical landmark found halfway between the pubic symphysis
and anterior superior iliac spine. It descends through the anteromedial aspect of the
thigh through the adductor canal and distally goes posterior through the adductor hiatus
to become the popliteal artery. In the proximal thigh the femoral artery is referred to as
the common femoral artery and its branches include the superficial epigastric artery,
superficial circumflex iliac artery, superficial external pudendal artery, deep external
pudendal artery, and the profunda femoris. Distal to the profunda femoris, the common
femoral artery becomes the superficial femoral artery and provides muscular branches
to sartorius, vastus medialis, the adductors, as well as the descending genicular artery
branch. The profunda femoris supplies the hip joint as well as muscles in all three
osteofascial compartments. Branches include the lateral and medial circumflex femoral
arteries, four perforating arteries (terminal profunda is the forth) as well as muscular
branches to the adductors and posterior compartment muscles22.

2.3
2.3.1

Anatomy of the Knee Joint:
Osteology:

The knee is a modified hinge type synovial joint that has two articulations, the
tibiofemoral joint and patellofemoral joint. The three bones that make up these joints are
the femur, tibia, and patella.
The tibiofemoral joint is the articulation point between the distal femur and proximal
tibia. The joint surfaces are made up of the convex surfaces of medial and lateral
condyles of the distal femur which are in contact with the articular facets on the medial
and lateral condyles of the tibial plateau. Their surfaces are covered in a layer of
articular cartilage to allow smooth, low friction movement25.
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Distally on the femur, the lateral epicondyle serves as the origin on the lateral collateral
ligament, while the medial epicondyle is the same for the medial collateral ligament. The
trochlear groove is a depression anteriorly on the femur that stabilizes the patella in the
patellofemoral joint during range of motion. Inferiorly and posteriorly is an area called
the intercondylar fossa where the anterior and posterior cruciate ligaments are found.
The tibial plateau slopes posteriorly and downwards in relation to the tibial shaft and is
where the intercondylar eminence or tibial spine is found. Two prominences can be
found here, the medial and lateral intercondylar tubercles, anterior to which the anterior
horns of the medial and lateral menisci insert as well as the anterior cruciate ligament.
Posterior to the tubercles, the posterior horns of the menisci and posterior cruciate
ligament insert onto the tibia. Inferior to the joint line, and on the anterior aspect of the
tibia, is where the tibial tuberosity is found and is the insertion point for the patellar
tendon. Lateral and superior to this area, another prominence called Gerdy’s tubercle
serves as the insertion site for the Iliotibial tract2225.
The patella is the largest sesamoid bone in the human body and is encapsulated by the
quadriceps tendon. With flexion and extension, the patella articulates with the distal
femur in the trochlear groove. Posteriorly on the patella, different areas are in contact
with the femur during the knee joint’s range of movement. The upper medial and lateral
facets are in contact with the femur during flexion, the lower medial and lateral facets
during extension, and the medial vertical facet during extreme flexion25.
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Figure 4: The knee joint
Reprinted with permission from theodora.com/anatomy

2.3.2

Muscles and Popliteal Fossa:

The muscles responsible for knee joint movement are found in table 5.
Table 5: Muscles responsible for knee movement
Movement

Muscles

Knee Flexion

Biceps femoris, semimembranosus, semitendinosus
(assisted by gracilis, sartorius, gastrocnemius, and plantaris)

Knee Extension

Rectus femoris, vastus lateralis, vastus medialis, vastus
intermedius

Medial Rotation (flexed leg)

Popliteus, semimembranosus, semitendinosus (assisted by
sartorius and gracilis)

Lateral Rotation (flexed leg)

Biceps femoris
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A unique muscle to the knee joint is the popliteus. Popliteus is innervated by the tibial
nerve (L4-5, S1) and forms the floor of the popliteal fossa and is intracapsular, but
extra-synovial to the knee joint. Its origin is the lateral aspect of the lateral femoral
condyle and inserts on the posterior surface of the tibia, proximal to the soleus line. Its
function is to rotate the tibia medially or the femur laterally to unlock a fully extended
knee at the beginning of flexion22.
Posteriorly, the hamstring and medial and lateral heads of gastrocnemius form the
borders of the popliteal fossa. The popliteal fossa has a diamond shape, and its borders
laterally are the biceps femoris proximally and the lateral head of gastrocnemius distally.
Medially, semimembranosus and semitendinosus are the proximal medial border, while
the medial head of gastrocnemius makes up the distal medial border. The floor (anterior
boundary) is made up of the posterior aspect of the femur, the oblique popliteal
ligament, posterior capsule of the knee joint, and popliteus with its associated overlying
facia. The roof (posterior boundary) is the popliteal facia. The contents of the popliteal
fossa include the common peroneal and tibial nerves (most superficial structure), sural
nerve, short saphenous vein, popliteal lymph nodes, posterior cutaneous nerve of the
thigh, genicular branch of the obturator nerve, fat, and the popliteal vein and artery
(deepest structure).

2.3.3

Ligaments:
There are four major ligaments that stabilize the knee joint in different planes, the

anterior and posterior cruciate and medial and lateral collateral ligaments. The anterior
cruciate ligament (ACL) is responsible for restricting anterior movement of the tibia in
relation to the distal femur. It originates on the posteromedial aspect of the lateral
femoral condyle and distally inserts anterolaterally to the medial tibial eminence,
blending with the anterior horn of the lateral meniscus. The posterior cruciate ligament
(PCL), resists posterior translation of the tibia in relation to the distal femur, and is
thicker and stronger than the ACL. It originates from the lateral aspect of the medial
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femoral condyle and extends to the roof of the intercondylar notch. Crossing posterior to
the ACL, it distally inserts onto the posterior tibia in the intercondylar region22,25.
The medial collateral ligament is attached to the medial epicondyle of the distal femur,
and resists valgus producing forces on the knee joint. Its deep fibres are attached to the
medial meniscus and distally inserts onto the medial condyle and body surface of the
tibia, approximately 2.5cm distal to the condyle. On the lateral aspect of the knee joint,
the lateral collateral ligament works to resist varus producing forces and is attached to
the lateral femoral epicondyle. Its insertion distally is on the fibular head, and in contrast
to the MCL, is not adherent to the lateral meniscus as it descends.

2.3.4

Meniscus:
The medial and lateral menisci of the knee are fibrocartilaginous structures that

increase tibiofemoral congruency, act as a secondary stabilizer for the knee joint,
minimize tibiofemoral contact pressure, and contribute to joint lubrication and articular
cartilage nutrition 25. These crescent shaped intracapsular structures are poorly
vascularized and cover approximately two thirds of their associated articular surfaces.
Each possess an anterior and posterior horn, highly innervated areas compared to the
rest of the meniscus that provide attachment points centrally on the tibia. The medial
meniscus is semi-circular in shape and its anterior horn is attached anterior to the
insertion site of the ACL in the intercondylar area of the tibial plateau. Its posterior horn
also attaches to the tibia in the intercondylar area, though its insertion is more posterior
between the insertion of the PCL and the posterior horn of the lateral meniscus. Unlike
the lateral meniscus, the medial meniscus is also adherent to the joint capsule
peripherally as was all the deep fibers of the MCL. The shape of the lateral meniscus is
nearly a full circle, and its anterior horn inserts posterolateral to the ACL insertion and
its fibers blends into it. The posterior horn insertion is found between the tibial eminence
and the posterior horn insertion of the medial meniscus and uniquely uses
meniscofemoral ligaments attached to the medial femoral condyle to anchor its
position25.
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2.3.5

Capsule and Synovium:
The knee joint capsule is a tough fibrous layer surrounds the knee joint. Its

margins anteriorly include the patella and the patellar tendon. The capsule extends
posteriorly to the collateral ligaments and distally to the condyles of the tibia. The
posterior boundaries are the articular margins of the femoral condyles, intercondylar
notch, and posterior proximal tibia. The synovial membrane is a unique tissue that lies
deep to the capsule on the knee. Its function is the production of synovial fluid that
lubricates the tibiofemoral and patellofemoral joints during flexion and extension. Its
insertion is along the articular margins of the patella, femur and tibia and forms a large
suprapatellar bursa between the quadriceps tendon and the distal femur22.

2.3.6

Cutaneous and Articular Innervation:
The peripatellar plexus is a network of nerves responsible for sensation over and

around the patella. It arises from connections between the infrapatellar branch of the
saphenous nerve as it travels medial to anterior, medial femoral cutaneous nerve,
intermediate femoral cutaneous nerve, and the lateral femoral cutaneous nerve. Figure
5 displays the cutaneous distribution around the knee joint. The Intermediate femoral
cutaneous nerve provides anterior coverage, the saphenous nerve anteromedial, the
lateral sural cutaneous nerve laterally and the posterior cutaneous nerve of the thigh for
sensation posteriorly.
The articular innervation is through genicular branches from the obturator, femoral,
tibial, and common peroneal nerves. The posterior aspect is supplied by the genicular
branch of the obturator nerve, a terminal division of the posterior branch of the obturator
nerve. The femoral nerve branches to vastus medialis terminate as articular sensory
branches at the knee joint. The tibial nerve provides genicular branches that run with
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the medial and middle genicular arteries, and the common peroneal sends branches
that run with the lateral genicular artery as well as the anterior tibial recurrent artery22.

Figure 5: Knee joint articular innervation from anterior (A.), lateral (B.), and
posterior (C.)
Reprinted with permission by 26 Goldman DT, Piechowiak R, Nissman D, Bagla S,
Isaacson A. Current Concepts and Future Directions of Minimally Invasive Treatment for
Knee Pain. Curr Rheumatol Rep. 2018;20(9).

2.3.7

Blood Supply:
The arterial anastomosis surrounding the knee joint receives contribution through

a number of genicular branches of the popliteal, superficial femoral, lateral circumflex
femoral, posterior and anterior tibial arteries22. There are superior, middle and inferior
genicular artery branches arising from each of these larger vessels (figure 6). The
medial and lateral (deep and superficial) superior genicular branches come from the
popliteal artery, and curve around the femoral condyles anteriorly to supply the front of
the knee. The descending genicular artery, a branch of the superficial femoral artery,
anastomosis with the medial superior genicular artery. Further arterial connections
occur between the medial superior genicular artery and the inferior medial genicular
artery as well as the deep branch of the lateral superior genicular artery. The superficial
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lateral superior genicular artery anastomosis with the descending branch of the lateral
circumflex femoral artery as well as the inferior lateral genicular artery. The middle
genicular artery also stems from the popliteal artery and is responsible for the cruciate
ligament and synovial membrane blood supply. The medial and lateral inferior genicular
arteries arise from the popliteal artery as well. The lateral inferior genicular
anastomoses with the lateral superior, medial inferior, anterior and posterior recurrent
tibial arteries (branches of the anterior tibial artery), and circumflex fibular artery (branch
of the posterior tibial artery). Together, this complex network of vessels supply the knee
joint with arterial blood22.

Figure 6: Arterial anastomosis of the knee joint
Reprinted with permission from theodora.com/anatomy
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Chapter 3

3

Literature Review
3.1

Knee Joint Arthritis:

Arthritis occurs when there is a medical or structural condition that is promoting
inflammation within the joint. There are over 100 different diseases that cause arthritis
through a variety of pathophysiologic pathways that lead to localized bone and articular
cartilage destruction 27. Common etiologies include rheumatoid arthritis, seronegative
spondyloarthropathies 28, osteoarthritis, and post-traumatic. Though the pathological
process is different depending on the underlying cause, arthritic diseases share similar
symptoms and signs including joint pain, joint swelling, erythema, stiffness, loss of
range of movement, decreased function and significant disability.
In Canada, arthritis as a whole is the most prevalent chronic health condition that affects
1 in 5 people over the age of 15, and 1 in 2 seniors over the age of 65 27. It has a female
predominance with 59.5% of sufferers being women 27. The total economic burden
arthritis places on the Canadian economy was estimated to be 6.1 billion dollars in the
year 2000, 33 billion dollars in 2010 and is projected to be 67 billion dollars by 2031.
This steady rise is primarily due to the aging population and rising incidence of obesity
as both are strong risk factors for arthritis29,30. In the knee, the most common arthritic
conditions are osteoarthritis, rheumatoid arthritis, and post-traumatic arthritis (secondary
osteoarthritis) 31,32

3.2

Knee Osteoarthritis:

Also known as degenerative arthritis or degenerative joint disease, osteoarthritis
(OA) is a condition characterized by articular cartilage deterioration and sclerosis of the
underlying bone 33,34.
The knee is the most common site for osteoarthritis followed by the hand and hip
joints35–37. The age and sex standardized incidence of knee osteoarthritis is 240/100000
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with the annual incidence in Canada expected to rise from e 30,35,38. Knee OA accounts
for approximately 80% of the overall osteoarthritis disease burden39. Being the most
common arthritic condition affecting the knee joint, in 2016, primary total knee
arthroplasty was performed for a diagnosis of OA in 98.8% (n=46,241) of cases in
Canada40. Because of this, knee OA carries a significant economic and public health
burden.
The exact etiology of osteoarthritis can be difficult to determine, but the overlying
diagnosis is divided into two separate types, primary and secondary. Primary or
idiopathic OA is associated with aging and said to have occurred when there is no
identifiable initiating event or major risk factors such as previous trauma or obesity34,41.
As articular cartilage ages, imbalances in chondrocyte metabolic pathways and changes
in the extra-cellular matrix occur as a result of a number of fundamental biologic
processes42,43. These include increased matrix degradation, reduced matrix repair,
increased cell death, chondrocyte hypertrophy, calcification and crystallization,
subchondral sclerosis, osteophyte formation, focal bone remodeling and synovitis 41.
These age-related changes are responsible for the major pathologic features of OA
which consist of articular cartilage degradation, ligament and meniscus degradation,
subchondral sclerosis, osteophyte formation, and joint capsule hypertrophy 41.
Secondary osteoarthritis occurs as a result of a precipitating factor such as previous
injury to articular surface, meniscus or ligaments (post-traumatic arthritis), surgery,
obesity, concomitant rheumatoid arthritis, gout, diabetes, or congenital joint
abnormalities 38.
There are two diagnostic definitions for OA, the first being radiographic osteoarthritis.
The diagnosis of radiographic OA is made with the application of the Kellgren Lawrence
classification which is a graded assessment of weight bearing films for the radiographic
features of OA including joint space narrowing, subchondral sclerosis, and deformity of
bone contour38,44. A Kellgren Lawrence grade of ³ 2 is diagnostic of radiographic OA.
The second diagnostic definition is symptomatic OA, which is the presence of
radiographic OA (Kellgren Lawrence grade of ³ 2) as well as symptoms such as pain
and stiffness in the same knee 45,46. It is important to distinguish the two because
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symptomatic OA is the more clinically relevant diagnosis as it carries the most
morbidity, disability, and public health burden 45. In the Johnston County Osteoarthritis
Project, it was found that though a positive association between the presence of
radiographic features of OA and patients having pain exists, a large group of patients
demonstrated radiographic findings that were asymptomatic and not limiting activity (47.
The Framingham study demonstrated the prevalence of radiographic OA of the knee to
be 33% (43% women, 31% men) in patients aged 63-94. In this same group, the
prevalence of symptomatic OA of the knee was only 9.5% (11.4% women, 6.8% men)
36

. The incidence of OA varies due to study population age and disease definition

utilized 48. Studies that utilize radiographic diagnostic criteria result in a higher incidence
rate as the severity of radiographic features and disability aren’t strongly correlated 47–50.
Several risk factors for OA have been identified and include age, female gender, family
history, obesity, nutrition, previous major or repeated minor trauma or surgery,
occupational (athletes, laborers), joint malalignment, muscle weakness and sedentary
lifestyle275145. In a large population-based study, the lifetime risk of developing
symptomatic knee OA was found to be 44.7% (95% confidence interval [95%CI] 40.049.3%)45. When participants had a history of previous knee trauma or BMI >30, the
lifetime risk rose to 56% (95% CI, 48.4-65.2) and 60.5% (95%CI, 53.0-58.1)
respectively, providing proof that these risk factors are particularly important in the
development of knee OA45.

3.3
3.3.1

Treatment Options:
Non-operative treatment:

Osteoarthritis of the knee can be managed with a variety of conservative and
pharmacologic options before considering surgery. Typically, these modalities are more
effective with relieving symptoms in patients who have mild to moderate OA, though
they should still be considered first-line therapy in all patients regardless of age,
functional ability, radiographic findings, pain level, and comorbidities 52. Conservative
management includes the use of exercise, weight loss, knee braces, walking aids,
transcutaneous electrical nerve stimulation (TENS), local heat, and activity modification.
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These treatments have been shown to have significant benefit for patients, and are
often successful with managing mild symptoms, avoiding the use of pharmacologic
therapy52.
In terms of pharmacologic management, options that can be utilized in patients with
moderate to severe symptoms include oral and topical medications as well as
intraarticular injections.52,53. Non-steroidal anti-inflammatories, selective
cyclooxygenase-II (Cox-2) inhibitors, acetaminophen, tricyclic antidepressants, and
selective serotonin and norepinephrine reuptake inhibitors (SNRI) make up the majority
of oral pharmaceutical options in the management of osteoarthritis. Some oral
supplements such as glucosamine and chondroitin can be used as well, but the
evidence is conflicting in regard to their efficacy 52. Opioids should not be routinely
utilized as they come with a number of side effects such as constipation, nausea,
sedation, dizziness, dependency, and addiction 52. A large systematic review found only
a small effect size (standardized mean difference (SMD-0.28, 95% CI, -0.35 to -0.20) of
non-tramadol narcotics compared to placebo. This corresponds to a 0.7-point difference
on the visual analogue scale for pain and a number needed to treat to produce one
additional treatment response of 10 (95% CI, 8-14). This indicates that narcotics are not
highly effective in the management of pain in OA 54.
Intraarticular injections consist of three categories; corticosteroids, hyaluronic acid, and
platelet rich plasma. Their mechanism of action varies, but they all work by reducing
intraarticular inflammation once administered inside the joint 53. Vannabouathong et al.55
performed a systematic review of 10 meta-analysis looking at pharmacologic treatments
for knee osteoarthritis compared to oral placebo. What they found was, after controlling
for the intraarticular injection placebo effect, high molecular weight hyaluronic acid
injections (SMD-0.58, 95% CI, 0.36-0.79) provided the most precise treatment effect
estimate that surpassed their threshold of clinical importance (set at 0.50 standard
deviation). The treatment with the greatest point estimate of treatment effect was
platelet rich plasma but was also the least precise (SMD-0.77, 95% CI, -0.29-1.83)
indicating significant uncertainty in its results 55. In cases of moderate to severe OA
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where joint symptoms persist despite the compliant use of non-operative treatments,
referral for surgery is indicated.

3.3.2

Arthroplasty

Surgical options for knee arthritis include distal femoral or proximal tibial osteotomies,
unicompartmental knee arthroplasty, and total knee arthroplasty 56. Total knee
arthroplasty is the gold standard for patients who have severe OA symptoms and have
failed all previously tried conservative and medical management strategies 56,57.
The first iteration of what would become the modern total knee implant was developed
in 1970 by Peter Walker, John Insall, Chitranjan Ranawat, and Alan Ingis. Named the
duocondylar knee, it was an anatomic, cemented, partial condylar component that
preserved both cruciate ligaments. Later it evolved into the duopatellar knee design that
is more closely related to current implants 58. Today, primary total knee prostheses are
comprised of two to four components of varying materials depending on the brand and
model. They include a distal femoral component, a tibial base plate, tibial tray liner, a
single tibial tray and liner combination implant, and patella resurfacing implant. The liner
acts as a low-friction bearing surface for the femoral component to articulate with.
These implants also adhere to two major design types; fixed-bearing and mobilebearing. Though not definitively proven in the literature, mobile-bearing designs allow
for motion to occur between the tibial tray and liner with the intention of reducing
component wear, loosening, and subsequent failure by improving range of movement
59

. The procedure involves guided cutting and resection of the articular surfaces of the

femur and tibia. During this process, the damaged articular cartilage is removed, while
the surgeon also takes into account final component alignment in the sagittal and
coronal planes 57. Recent innovations include the use of computer navigation and
patient specific jigs that intend to decrease error, improve accuracy, and assist in
difficult primary cases where standard alignment tools can’t be utilized 57,60. Following
preparation of the femur and tibia, trial components are used to ensure proper
positioning and sizing of the prosthesis. The final components are then inserted using
either a press-fit or cemented implant design to maintain the desired alignment and
restore knee joint kinematics 57. Patients who undergo total knee arthroplasty have
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successful outcomes with significant improvement in pain and functional limitation
experiences pre-operatively 5,57,61,62.

3.4

Arthroplasty in Canada:

The need for total knee arthroplasty in Canada is increasing each year. In the year
1999, the Canadian Joint Replacement Registry (CJRR) reported that 22,302 total knee
replacements were performed 63. By 2016, this number had risen to 67,169 procedures,
a threefold increase in 17 years 40. This trend is also being seen in the United States,
where the number of total knee arthroplasty procedures is expected to rise by 673%
from 450,000 in 2005 to 3.48 million in 2030 64. As the societal demand and resource
utilization for this procedure has increased, our post-operative care has become more
efficient allowing for patients to be discharged earlier. During that same time period, the
mean length of stay in hospital shrank from a mean of 8.5 days in 1999 to 3 days by
2016 indicating our understanding of total knee arthroplasty and its post-operative care
are evolving40,63.

3.5

Post-operative Pain:

A common concern shared by patients undergoing total knee arthroplasty is how well
their post-operative pain will be managed. Poorly managed pain following surgery is an
important consideration as it can directly affect ambulation, sleep, ability to perform
physiotherapy and result in prolonged discharge from hospital 65–68. Factors that are
associated with an increase in severity of post-operative pain include female gender,
pain catastrophizing, pre-operative depression, younger age, high pre-operative pain
level and longer duration of pain 66,69–71. The acute pain following surgery is most severe
in the early stages, specifically post-operative days one to three, making early
intervention a priority 65,67. Decreased ambulation and rehabilitation due to poorly
managed pain can also contribute to complications such as deep vein thrombosis,
pulmonary embolus, and pneumonia 72.
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Studies have indicated that poorly managed acute post-operative pain also increases
the risk of developing chronic pain following total joint arthroplasty 73,74. Baker et al. 5
demonstrated chronic pain to be a stronger determinant of overall satisfaction, even
more so than functional impairment, and thus acute pain can have effect on satisfaction
following TKA 5. Therefore, adequate analgesia is essential to ensure expedited
discharge, decreased short and long term post-operative complications, and improved
patient satisfaction.

3.6

Analgesic Medications:

As pain is a complex and difficult aspect of the post-operative management, healthcare
professionals utilize a number of analgesic options to decrease the noxious stimuli that
follow total knee arthroplasty. Nociceptive pain information travels towards the brain
through afferent sensory nerves when they are stimulated peripherally, and analgesic
medications work to inhibit this pathway at varying levels. Depending on their
mechanism, common analgesic medications decrease the intensity of the pain sensory
pathway by interacting with it at different levels 53. Narcotic medications, or opioids, are
utilized in the early and most severe stages of pain post-operatively 69,75. They depress
nociceptor neuron activity through the central activation of opioid receptors, resulting in
analgesia at the surgical site76. Opioids have traditionally been delivered through
patient-controlled analgesia, giving patients the choice of when to deliver doses through
a computerized pump in an attempt to reduce total consumption, and maintain
satisfaction 77. Though effective, opioids come with host of adverse effects including
nausea, vomiting, pruritus, urinary retention, constipation, confusion, sedation, and
more severe complications like respiratory depression, tolerance, addiction, and death
75,78

. Halawi et al. 75 found in a population of 673 total joint arthroplasties, 8.5% of

patients suffered from a complication as a result of narcotic medication, and these
events accounted for 58.2% of the total complications in the study. As a result, length of
stay was significantly prolonged (p<0.001) in patients who suffered from an adverse
event related to opioids 75. The demand to find effective alternative analgesics has been
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present for some time now, with studies beginning as far back as 1985 looking at the
effect of opioids on arthroplasty patients 78.
A more modern approach to analgesia for arthroplasty patients is the use of multi-modal
analgesia. Multi-modal analgesia provides a more comprehensive analgesic strategy by
using multiple drug classes for improved post-operative analgesia, decreased risk of
major drug related complications, and an expedited discharge can be achieved without
significant narcotic use 69,77,79. Multi-modal analgesia combines systemic analgesics
such as non-steroidal anti-inflammatories (NSAIDs), acetaminophen, neuropathic
medications, and minimal opioid medications with neuraxial and peripheral anaesthetic
techniques to ensure adequate pain management 79. Lamplot et al. 77 performed a
randomized controlled trial on patients who had undergone total knee arthroplasty.
Patient-controlled hydromorphone analgesia served as the control group, where the
experimental multi-modal group received intra-operative periarticular infiltration with
bupivacaine, with scheduled post-operative opioids (oxycodone, tramadol) and NSAIDs
(ketorolac). Total and daily narcotic consumption was found to be significantly lower in
the multi-modal group (p<0.0004 and p<0.007 respectively). The multimodal group also
had significantly less narcotic related side effects while in hospital (p<0.01) as well as
following discharge (p<0.01). They also found a difference in VAS pain scores at rest
(p<0.0004) and during activity (p<0.001) between groups favoring the multi-modal group
and that they met physiotherapy milestones faster. As they had only blinded the
outcomes assessors, a decision was made to end the trial early as there was
unanimous agreement amongst care providers that multi-modal analgesia was superior
77

.

3.7

Regional Anaesthesia:

Regional anaesthetic blocks provide a non-opioid option for post-operative analgesia
following total knee arthroplasty and promote early ambulation, decrease opioid
consumption, and as a result, decrease length of stay in hospital 12,80–82. A common
local anaesthetic that has shown to be a potent analgesic with a favorable safety profile
is ropivacaine. Ropivacaine is an amino-amide local anaesthetic that blocks nerve fiber
impulses through reversible inhibition of sodium ion channels, inhibiting afferent
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nociceptive information 83. Compared to other local anaesthetics such as bupivacaine, it
is less lipid soluble, and thus has less risk of central nervous system and cardiac toxicity
84,85

. In the setting of regional anaesthesia, it can be combined with NSAIDs such as

ketorolac, which inhibits prostaglandin inflammatory mediators, increasing its analgesic
quality and further reducing opioid consumption 77. Epinephrine can also be added to
the cocktail to cause localized vasoconstriction, which prolongs the effect of the local
anaesthetic by having less resorption 17. Andersen et al. 86 compared two different local
infiltration cocktails, the control being ropivacaine with epinephrine and the experimental
being ropivacaine, epinephrine with ketorolac. They found that a significant reduction
(p<0.0001) in morphine consumption at 0 to 48 hours post-op, as well as lower VAS
pain scores at rest and during movement from 0 to 48 hours post op in the group who
received ketorolac (p=0.02) 86.
Regional anaesthetic can be delivered using a number of different techniques described
in the literature 87,88. In the setting of total knee arthroplasty, common techniques
include epidural analgesia, femoral nerve blocks, adductor canal block, and periarticular
infiltration 88. Both peripheral nerve blocks and periarticular infiltration decrease opioid
consumption, but each have their own benefits and disadvantages 80–82. Peripheral
nerve blocks are an effective analgesic technique for total knee arthroplasty without the
side effects associated with systemic or epidural analgesia. Some potential
complications that can occur with peripheral blocks though include dense motor
blockade that impairs early ambulation and increases the risk of falling, infection from
an indwelling catheter, neurologic and vascular injury during the procedure, and
anaesthetic toxicity 88,89. Periarticular infiltration reduces the risk of motor blockade and
neurovascular injury while providing excellent analgesia 82. Its relative simplicity and
reduced procedure time and cost compared to peripheral nerve blocks make it an
attractive analgesic modality 88. Difficulty with delivering continuous anesthetic to the
surgical site is a limitation of periarticular infiltration. It relies on diffusion of anaesthetic
within the tissue surrounding the knee to achieve analgesia, and there is apprehension
in the surgical community with leaving indwelling catheters due to concerns for
prosthetic joint infection 69. An issue with the literature comparing regional anaesthetic
methods is the vast heterogeneity that exists between studies because of variable
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anaesthetic drug choices, concentrations, doses, infusion rates and assessment
protocols. Generalizations on efficacy of analgesia, ambulation ability, morphine
consumption, and complication rates are challenging to make, but consistencies are
seen between studies.

3.8

Single versus Continuous Regional Anaesthetic:

Procedural options for regional anaesthesia include single-shot or continuous infusions
of local anaesthetic through an indwelling catheter depending on the desired duration of
analgesia and discharge plan 82. The constant administration of local anaesthetic
around a targeted nerve or the surgical site allows for effective analgesia. The benefit of
having an indwelling catheter is the ability to administer further doses of anaesthetic to
prolong the duration of analgesia 81,90–93. Some concerns with continuous blocks and
catheters though are the increased risk of infection, retained catheter components,
catheter blockage or dislodgement, and anaesthetic toxicity 81,89,93,94. Current evidence
has provided little direction for a superior infusion medication, drug concentration, and
infusion rate for continuous blocks and thus these choices are made by surgeon and
anesthetist preference, resource availability, and experience 24,88.

3.9
Single-shot Adductor Canal and Motor-sparing Nerve
Blocks:
The medial compartment of the thigh contains a triangular shaped canal called the
adductor canal. The muscular borders of the adductor canal are formed by sartorius
anteriorly, vastus medialis anterolaterally, and posteromedially by adductor longus and
magnus 22,24. The contents of the canal include the femoral artery and vein, descending
genicular and muscular branches of the femoral artery, the saphenous nerve (femoral
nerve sensory branch), and the nerve to vastus medialis prior to its insertion into the
muscle 22,24. First described by van der Wal in 1995, local anaesthetic can be delivered
here under ultra-sound guidance or through nerve-stimulation to anaesthetize the
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saphenous nerve and provide a largely isolated sensory block to the anterior aspect of
the knee 24,95. Adductor canal blocks have gained popularity in recent years due to their
reduced risk of motor blockade causing quadriceps weakness which can result in
delayed rehabilitation and discharge in comparison to femoral nerve blocks and epidural
analgesia 24,87,90,96–98.
Prior to adductor canal blocks, femoral nerve blocks were a successful peripheral nerve
block in TKA patients and removed risks like neuraxial haematomas that are associated
with epidural infusions 87. One of the complications associated with femoral nerve
blocks is dense motor blockade due to the proximal site of anaesthetic administration
80,97–99

. As adductor canal blocks target saphenous nerve, a sensory branch of the

femoral nerve, the risk of quadriceps weakness occurring has been shown to be
significantly reduced while still providing excellent analgesia when compared to femoral
nerve blocks 24,97–99. Jaeger et al. 99 performed a randomized, double-blinded, and
placebo controlled cross over study comparing quadriceps strength between adductor
canal and femoral nerve blocks. Twelve volunteers received an active adductor canal or
femoral nerve block randomized to either their right or left leg and a placebo in the
contralateral side. Subjects returned for a second study day to receive the opposing
active block depending on what they had first. Active peripheral blocks were performed
using 30 milliliters (ml) of 0.1% ropivacaine, with isotonic saline as the placebo, under
ultrasound guidance. The primary outcome measure was quadriceps strength
measured via maximum voluntary isometric contraction (MVIC) in the leg that received
an adductor canal block versus placebo. Secondary outcomes were the difference in
quadriceps strength between adductor canal and femoral nerve blocks, difference in
adductor strength, and mobilization at one and six hours following the procedure (timed
up and go (TUG), 10-meter walk test and 30-second chair stand test). The investigators
and subjects were blinded during the study and the study was sufficiently powered
(power 80%, a=0.05, sample size=10). Baseline quadriceps MVIC measurements were
taken, and a 25% reduction set as the minimally clinically important difference as a 10%
difference between subject’s legs is normal. Eleven study subject’s data were analyzed
finding a significant difference in MVIC between adductor canal and femoral nerve
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blocks (p=0.002) as well as between placebo and femoral nerve blocks (p=0.0004). The
mean difference in MVIC in adductor canal blocks was 8% less than baseline, whereas
in the femoral nerve block group it was 49% less. Adductor strength was significantly
different (p=0.007) between femoral nerve blocks and placebo, with femoral block
causing more adduction weakness, but no difference was observed between adductor
canal and femoral blocks. Regarding the functional tests, subjects demonstrated a
significant reduction in time to perform both the TUG (p=0.002 at one hour, and p=0.008
at 6 hours) and 10-m walk tests (p=0.005 at one hour, and p=0.002 at 6 hours) at both
assessment points with the adductor canal block compared to femoral nerve block.
Additionally, adductor canal blocks offered a significant advantage over femoral nerve
blocks in the 30-second chair stand test (p=0.007 at one hour, and p=0.02 at 6 hours).
The most striking finding in this study was the reduction in quadriceps strength between
adductor canal and femoral nerve blocks. An 8% reduction wasn’t considered significant
for the adductor canal block as a 10% difference can exist between subject’s legs
normally, but a 49% reduction from a femoral block could delay rehabilitation and
increase fall risk 99.
These results have been replicated in a number of other randomized controlled trials
comparing adductor canal and femoral nerve blocks 97,98. Kwofie et al. 98 also performed
a blinded randomized control trial comparing quadriceps strength between adductor
canal and femoral nerve blocks. Similarly, their primary outcome was maximum
voluntary contraction at 30 and 60 minutes following the procedure. Secondary
outcomes included adduction strength at 30 and 60 minutes as well as Berg Balance
Scale (BBS) serving as a functional outcome at 30 minutes after the block. The study
protocol called for participants to receive an adductor canal block in one leg and a
femoral block on the contralateral side with each block utilizing 15ml of 3%
chloroprocaine under ultrasound guidance. The study was sufficiently powered with
sixteen healthy volunteers (power=0.8, a= 0.05, sample size=14) enrolled and a 50%
difference in quadriceps strength being set as clinically important. MVIC was
significantly improved with adductor canal blocks, with a mean of 95.1% of MVIC
preserved compared to only 11.1% in femoral blocks at 30 minutes following the
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procedure. At 60 minutes, a significant difference was still present, with 98.8% of
baseline MVIC preserved in with adductor canal blocks and 41.2% in femoral blocks. No
differences in adduction strength were observed. BBS was significantly impaired in the
femoral nerve block group (p=0.02) 98.
Grevstad et al.97 reported similar findings in their 2015 study, where the difference in
MVIC between adductor canal and femoral nerve blocks was compared in postoperative patients. Fifty patients were randomized to either adductor canal (n=25) or
femoral nerve block (n=25) on post-operative day one or two. Patients received both
procedures and blinding of the care providers was done by having pre-prepared
containers containing either 30mL of 0.2% ropivacaine or 30mL of saline equally
distributed between the two blocks. MVIC at 2 hours following the procedure served as
the primary outcome and was expressed as a percent of the baseline MVIC. The
secondary outcomes were VAS pain at rest and activity, adductor strength and the TUG
test for functional assessment at 2 hours post-procedure. The minimal clinically
important difference of MVIC between groups was set at 20%, and the study was
sufficiently powered (power=0.9, a=0.05, sample size=22). Median MVIC significantly
improved from baseline by 193% (95% CI, 143-288%) following adductor canal block
versus 16% (95% CI, 3-33%) for femoral blocks, an estimated difference of 178% (95%
CI, 136-226%, p<0.0001). The TUG test was performed significantly faster in the
adductor canal block group with a mean difference between groups of 20 seconds (95%
CI, 9-30s, p=0.001). It was also noted that six of the femoral nerve block patients were
unable to perform the TUG at 2 hours due to dense motor block of the quadriceps. No
differences were found in VAS scores at rest and with activity as well as adductor
strength 97. These studies unfortunately had small sample sizes and failed to compare
the more clinically relevant outcomes of post-operative pain reduction and function at
24-48 hours post-op. What they did demonstrate though was the motor protecting
quality of an adductor block compared to femoral nerve blocks in healthy and postoperative subjects.
Studies have shown the analgesic efficacy of adductor canal blocks and femoral nerve
blocks to be similar. Kuang et al.100 performed a systematic review and meta-analysis of
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9 recent randomized controlled trials involving 609 patients (668 knees) comparing
adductor canal and femoral nerve blocks with VAS scores with rest and activity as the
primary outcome. Secondary outcomes included quadriceps strength (manual muscle
testing (MMT) and MVIC), opioid consumption, patient satisfaction, and length of stay in
hospital. The Grading of Recommendations Assessment, Development, and Evaluation
(GRADE) process was utilized to assess the quality of the evidence for each outcome.
No significant differences in VAS scores were found at rest at 24 hours (7 studies
included, p=0.97) and at 48 hours (6 studies included, p=0.23). With activity, no
significant differences were found between groups at 24 hours (7 studies included,
p=0.30) and 48 hours (7 studies included, p=0.18). Quadriceps strength between
groups was significantly different, favoring the adductor canal block group at 24 hours
(p=0.002) with MVIC, and at 8 (p=0.04), 24 (p=0.03) and 48 hours (p=0.04) with MMT.
No other secondary outcomes were found to be significant between groups 100. They
concluded that adductor canal blocks can provide similar analgesia to femoral blocks,
while avoiding mobility issues due to quadriceps weakness, and recommended its use
in the total knee arthroplasty population.
The knee joint is innervated by the femoral and obturator nerves anterolaterally and
sciatic nerve posteriorly. A motor-sparing nerve block (MSNB) includes an additional
two single-shot injections in the posterior pericapsular area and around the lateral
cutaneous nerve of the thigh to provide more anaesthetic coverage than a standard
adductor canal block 12. Our centre previously performed a randomized controlled trial
comparing motor sparing nerve block and periarticular infiltration. Sogbein et al. 12
randomized 82 primary TKA patients to receive either a motor- sparing nerve block
(experimental, n = 41) or periarticular infiltration (control, n = 41) to compare betweengroup duration of analgesia. Patients were enrolled between July 2014 and June 2015
and randomization was stratified by age and surgeon to ensure that the groups were
balanced with respect to these factors. The primary outcome measurement was
analgesic duration, measured as time from end of MSNB/Infiltration administration to
end of effective analgesia (i.e. pain score at rest/activity >6 on the 11-point NRS and
initiation of rescue analgesia). Secondary outcomes included quadriceps strength
(MVIC), TUG test, patient reported outcome data (Western Ontario and McMaster
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University Osteoarthritis Index, Short-Form-12 Survey, and Knee Society Score),
narcotic consumption and side effects, and length of stay. Both the motor-sparing nerve
block and infiltration groups received a drug cocktail of 0.5% ropivacaine, 2.5mcg/mL
epinephrine, 10mg of morphine, and 30mg of ketorolac. The motor-sparing nerve block
consisted of a posterior knee infiltration injection of 20mL, a lateral cutaneous nerve of
the thigh block with 5mL, an intermediate cutaneous nerve of the thigh block delivered
under the fascia lata at mid-thigh of 10mL and finally, the adductor canal was injected
with 25mL for a total of 60mL. Intraoperatively, the periarticular infiltration group was
infiltrated with 100mL of the study drug. Randomization was performed by research
assistants not involved in the study, while the patients, surgeons, anaesthetists, and
outcome assessors were all blinded to avoid selection, performance, and detection
biases. Patients were analyzed on an intention-to- treat basis, using ANCOVA to
compare outcomes and a post-hoc Bonferroni correction to adjust for multiple
comparisons error. The study was sufficiently powered and used an equality samplesize calculation to detect the minimal clinically important difference (power=0.8,
a=0.05). MSNB provided significantly longer duration of analgesic effect, with a mean
difference of 8.8 hours (95% CI= 3.98-13.62 hours, p<0.01) compared to periarticular
infiltration. MSNB also had statistically significant lower pain scores at 2- and 4-hours
post-op with activity, and 2 hours post-op at rest. All other time points and secondary
outcomes did not show significant differences. The results provided evidence that
MSNB is a suitable technique for pain management following TKA 12. This study was
considered part-one of a two-part regional anaesthetic trial and the methodology and
results framed what would become the current study.

3.10

Local Wound Infiltration:

In 2008, Kerr and Kohan first described in a non-randomized case series a multi-modal
anaesthetic technique they coined local infiltration analgesia (LIA), also known as
periarticular infiltration 101. Though wound infiltration with anaesthetic was not a new
concept, the use of large volumes combined with specific injection placement hadn’t
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been described in the literature previously. The tissues surrounding the knee including
the posterior joint capsule (30-50mL), lateral and medial joint tissue (30-50mL) as well
as the anterior wound edges (25-50mL) were systematically infiltrated with a total of
150-170mL of the study drug (0.2% ropivacaine, 10mcg/mL epinephrine, and 30mg
ketorolac) to provide complete anaesthetic coverage. An intra-articular catheter was
placed for bolus injections at the end of the surgical case. Their results were positive,
with 71% of patients being discharged post-op day 1 and no serious adverse effects
noted throughout the trial period 101. Similar to peripheral nerve blocks, LIA has
demonstrated a number of benefits over previous analgesic techniques. LIA has been
shown to decrease post-operative pain scores, decrease narcotic consumption, improve
early function and ambulation, and have less risk of complications associated with some
other regional anaesthetic procedures 17,77,81,82,88,101,102.
Busch et al. 17 performed a randomized controlled trial of 64 TKA patients comparing
LIA (n=32) to no injection (n=32). Patients were blinded as to what group they were
randomized to and the experimental injection consisted of a 100mL mixture of 400mg
ropivacaine, 30mg ketorolac, 5mg of epimorphine, and 0.6mL of epinephrine. Narcotic
consumption in the first 24 hours served as the primary outcome, with secondary
outcomes including VAS scores for pain and satisfaction, patient reported outcomes
(WOMAC, KSS), length of stay, and complications. Five patients had serum ropivacaine
levels drawn at 30 minutes, 1 hour, and 4 hours post-op and all patients underwent a
post-operative lower limb ultrasound for deep vein thrombosis (DVT) at post-op day 5.
In the infiltration group, narcotic consumption through PCA was significantly less at 6
hours (p<0.01),12 hours (p=0.016), and overall at 24 hours post-op (p<0.001). VAS pain
scores were significantly less in the post-anaesthetic care unit (PACU) (p=0.04) as well
as 4 hours post-op (p=0.007). Satisfaction scores were significantly higher in the LIA
group in PACU (p=0.016) and four hours post-op (p=0.016). None of the experimental
patients demonstrated toxic levels of serum ropivacaine, with the highest level being 2.5
times less than the level of toxicity, and one patient suffered a DVT in the infiltration
group. No other significant differences were present between groups. In conclusion,
they recommended the use of LIA in patients undergoing total knee arthroplasty as it
decreased narcotic consumption and improved pain scores and satisfaction 17. The
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results of this study were supported in a recent systematic review and meta-analysis of
38 RCTs by Seangleuluret al. 103 where LIA had significantly decreased VAS rest pain
scores at 24 hours post-op versus placebo or no injection after sensitivity analysis was
performed to remove narcotic and NSAIDs as potential confounders (n=24 studies).
Narcotic consumption at 24 (n=20 studies) and 48 hours (n= 10 studies) was also
significantly reduced in the LIA group compared to placebo or no injection. LIA patients
also had a shorter length of stay in hospital compared to controls (n=9 studies) 103.
Similar to adductor canal blocks, periarticular infiltration shares the benefit of sparing
motor function to the quadriceps muscles, resulting in less risk of weakness and
delayed rehabilitation. Li et al. 104 randomized 82 patients into three different groups,
LIA (n=26), adductor canal block (n=26), and femoral nerve block (n=29) to compare
numerical rating score (NRS) pain scores at rest and activity at 2, 6, 12, 24, 36, 48, and
72 hours post-op. Secondary outcomes included quadriceps and adductor strength at
the same time intervals using MMT, knee range of movement, TUG test, as well as total
daily ambulation. The peripheral nerve blocks were performed under ultrasound with
20mL 5g/L ropivacaine and 0.1mg adrenaline, and periarticular infiltration was with
90mL total of 2.5g/L ropivacaine and 0.1mg adrenaline injected throughout the joint.
Final analysis included 77 patients and revealed that LIA had significant lower NRS
scores than the nerve block groups at rest at 2, 6, and 12 hours post-op (p<0.05). No
differences were present at any other time points or during activity at any time points
between groups. The LIA group had significantly less total narcotic consumption when
compared to the nerve block groups (p<0.05). Quadriceps weakness was significantly
increased in the femoral nerve block group within the first 12 hours, but not after
(p<0.05). A significant difference in TUG test and daily ambulation distance was also
present, favoring LIA on post-op day one over both nerve block groups (p<0.05), and
was only significantly different from femoral nerve blocks on post-op day two (p<0.05).
The length of stay for the LIA group was significant as well, demonstrating a shorter
inpatient period compared to the nerve block groups (p<0.05) 104. This was a small
study, with little information being provided in regard to their power calculation, and it
likely was underpowered to make any definitive conclusions.
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A recent meta-analysis of 14 trials, including 1122 patients comparing LIA with femoral
nerve blocks contradicted these results, finding no statistically significant differences
between groups regarding narcotic consumption, pain scores at rest and activity,
functional outcomes and complications. They warned readers though to interpret the
results with caution as significant heterogeneity between studies existed and no firm
conclusions could be made 20.
Sardana et al. 105 reviewed the literature and compared LIA analgesia with adductor
canal blocks following total knee arthroplasty. They conducted a meta-analysis including
6 studies of 396 patients that had a high amount of agreement among quality
assessment scores using the Jadad scale. Quantitative analysis revealed the VAS pain
scores for the LIA group were significantly reduced (p=0.001) compared to adductor
canal blocks. A similar result was found when comparing the narcotic consumption,
with LIA have significantly less (p=0.03). Unfortunately, functional outcomes were not
able to be analyzed due to the significant heterogeneity between studies. They
concluded that LIA has the potential to improve post-operative pain and reduce narcotic
consumption compared to adductor canal blocks but could not make any definitive
conclusions, stating more literature is needed 105.
One of the limitations of LIA is the short duration of effective analgesia, ranging from 848 hours, and the challenge of developing a reliable method of continuous deliver
anaesthetic post-operatively 81,105. Numerous studies have been performed exploring
the idea using different medications, drug concentrations, and infusion rates with
variable results 106–110

3.11

Continuous Epidurals Analgesia:

Continuous epidural analgesia involves the placement of am indwelling catheter into the
epidural space to prolong the analgesic effect similar to peripheral nerve blocks. Prior to
the wide spread use of peripheral nerve blocks, neuraxial anaesthesia was a successful
regional analgesic option in orthopaedic surgery. Epidural analgesia has fallen out of
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favor though due to its tendency to cause concomitant motor block and concerns over
its safety profile 111,112. Neuraxial haematoma is a risk following epidural and is
increased in orthopaedic patients (1:4000) compared to other surgical procedures
(1:10000-20000). The reason for this is the use of early anti-coagulation in this patient
population due to the increased risk of venous thromboembolism 87,111. Gerrard et al. 96
performed a meta-analysis of 12 randomized trials comparing peripheral nerve blocks to
epidural analgesia and found that there were no statistically significant differences in
VAS pain scores a 0-12, 12-24, and 24-48 hours post-op between the two groups. What
was found was that epidurals significantly increased the risk of post-operative
complications including nausea and vomiting (p=0.002), hypotension (p=0.0009), and
urinary retention (p<0.0001) 96. Peripheral nerve blocks provide the same analgesic
benefit of epidural analgesia with less risk of complications 112.

3.12

Continuous femoral nerve blocks:

Femoral nerve blocks are a common regional anaesthetic technique due to their low
procedural difficulty and success with lower limb analgesia 113. First described by Labat
in 1920, they have risen in popularity in the last few decades in the orthopaedic
community 113–115. Local anaesthetic can be delivered through a single-shot or through a
perineural catheter to prolong the analgesic effect 80,113.
Chan et.al.113 randomized 200 patients prior to undergoing total knee arthroplasty to
three treatment options, Intravenous PCA (1mg morphine, 10mg/hr lockout), singleinjection femoral nerve block (20mL 0.25% bupivacaine with 2.5mcg/mL adrenaline),
and continuous femoral nerve block (20mL 0.25% bupivacaine with 2.5mcg/mL
adrenaline injection, followed by 0.125% bupivacaine 4mL/hr infusion). The primary
outcome for the study was significant pain with activity, defined as a VAS pain score of
greater than 4. Secondary outcomes included VAS pain score at rest, cumulative
narcotic consumption, side effects such as nausea and vomiting, number of days to
achieve 90 degrees of flexion range of motion, and complications. The study was
sufficiently powered, with a sample size of 60 (power=0.8, a=0.05) being calculated for
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the primary outcome. At the time of analysis, 64 patients were in the PCA group, 68 in
the single-injection group and 65 in the continuous infusion. Compared to PCA, the
proportion of patients who suffered from significant pain (VAS>4) was found to be
significantly lower in both the single-injection femoral block (OR 0.36; 95% CI 0.15 –
0.86; p=0.022) and continuous groups (OR 0.25; 95% CI 0.11 – 0.6; p=0.002). VAS
pain scores at rest were significantly lower in the continuous femoral block at 6 hours
post-op compared to PCA (p=0.018). VAS pain score with activity was found to be
significantly lower in both the single-injection group (p=0.045) and continuous femoral
nerve block group (p<0.0001) compared to PCA at 24 hours post-op. A significant
difference was also found at 24 hours between the two peripheral block interventions,
favoring the continuous nerve block (p=0.045), indicating the duration of effective
analgesia for the single-injection had passed. Both groups had significantly lower
cumulative narcotic consumption compared to PCA, and continuous peripheral nerve
blocks had significantly lower consumption than single-injection on post-op day 1
(p<0.001) and 2 (p<0.001). Regarding time to reach 90 degrees of flexion, both singleinjection (2.3 days, p=0.014) and continuous nerve block (2.4 days, p=0.024) groups
reached it significantly earlier than PCA (3 days). Nausea and vomiting were
significantly less evident in the nerve block groups, and no adverse events occurred
during the study period. They concluded that femoral nerve blocks provided superior
analgesia over PCA, with possible additional benefits of decreased narcotic
consumption, earlier functional recovery, and less side effects. Unfortunately, there was
no blinding at any level (patient, provide, or outcome assessor) during the study and
they recognized that small treatment benefit differences between single and continuous
femoral nerve blocks could not be found as their study wasn’t sufficiently powered to do
so 113.
Certain complications are a major concern with femoral nerve blocks. Feibel et al. 13
performed a retrospective review of patients who underwent total knee arthroplasty and
received a femoral nerve perineural catheter. Two groups of patients were established,
a group of 469 patients who had a femoral block infusion for 2-3 days post-op and
another 721 patients whose infusion was discontinued 12 hours post-op. In the 469patient group, 0.4% (n=2) suffered a nerve palsy, and 0.85% (n=4) sustained a fall due
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to motor weakness while in the 721-patient group, nerve palsies occurred in 1% (n=7),
with 0.2% (n=2) being permanent, and 0.55% (n=4) of patients had a fall. The overall
incidence of neurologic injury was found to be 0.6% in this study but has been quoted to
be as high as 1.2% following TKA 13,116. Though rare, neurologic injury possess a
potentially catastrophic outcome in TKA patients and patients should be cautioned.
Transient motor weakness is also an issue with femoral nerve blocks 89,90,93,113. The
rectus femoris, a major contributor to active knee extension, receives motor function
from two nerve branches of the femoral nerve. An anatomical study with cadaveric
specimens found the proximal and distal motor branches to rectus femoris can be found
8±2.12cm and 17.25±5.21cm distal to the femoral nerve at the inguinal ligament
respectively 117. The insertion site for the femoral block is proximal to both of these
motor branches and thus explains why quadriceps motor function can be compromised
following a femoral block 80,97–99. As a result of this, along with the success of adductor
blocks and Infiltration for analgesia, femoral nerve blocks have become a less attractive
option in modern arthroplasty care 114.

3.13

Continuous adductor canal blocks:

Similar to femoral nerve blocks, adductor canal blocks offer the option of adding a
perineural catheter to extend the duration of analgesia past what single-injection
techniques can provide 80. The benefit of adductor canal blocks compared to femoral
nerve blocks and epidural analgesia is the decreased risk of quadriceps weakness
which can limit rehabilitation and delay discharge 80,118,119.
Shah et al. 91 performed a randomized control trial comparing single-injection versus
continuous adductor canal blocks. The sample included 46 continuous and 39 singleinjection participants and was sufficiently powered to detect a clinically significant
difference of 10mm in VAS score (power=0.8, a=0.05, sample size=44). The singleinjection consisted of 30cc 0.75% ropivacaine injection, followed by repeated 30cc
saline boluses every 4 hours post-op. The continuous adductor canal block group
received a 30cc 0.75% ropivacaine injection as well, but a 30cc 0.25% ropivacaine
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bolus was delivered every 4 hours post-op. The primary outcome was VAS pain score
at 4, 8, 12, and 24 hours post-op, with secondary outcomes including TUG test, 10-m
walk test, 30s chair test, ambulation distance at discharge, maximum knee flexion at
discharge, and length of stay. They found that the continuous group had statistically
significant lower VAS pain scores at rest and during activity at 4, 8 ,12, and 24 hours
post op (p<0.001). There was also a significant difference in pain scores favoring the
continuous block group at rest and activity on post-op day 1 and 2 (p<0.001, p<0.001).
The timed up and go, 10-m walk, and 30s chair tests were used to assess ambulation
ability and though the continuous group had faster times, they were not significant.
Functional recovery outcomes (staircase competency, walker ambulation, ambulation
distance, flexion range at discharge) demonstrated no significant differences. Two
patients in the single-injection group required rescue opioid analgesia and none in the
continuous group, which was consistent with other studies. No other secondary
outcomes were found to have significant differences. They concluded at the end of this
study that adductor canal blocks provide excellent analgesia following TKA, with
continuous adductor canal blocks demonstrating superior analgesia over single-injection
91

.

One would expect this outcome, as intuitively, having the ability to deliver more
anaesthetic over time should yield a longer duration of analgesia. However, the results
comparing single-shot and continuous adductor canal blocks have been inconsistent.
Zhang et al. 120 performed a randomized, placebo-controlled trial comparing single-shot
adductor canal block, continuous adductor canal block and a saline control group (Y
zhang, ultrasound). The single-injection consisted of an ultrasound guided 20mL 0.5%
ropivacaine pre-operatively followed by two 20mL saline boluses at 12- and 24-hours
post-op. The continuous group received the same pre-operative regimen, with 20mLof
0.5% ropivacaine given at 12 and 24 hours, and the saline control group received saline
for all three injections. The primary outcome was visual analogue scale for pain during
activity, with secondary outcomes including opioid consumption, quadriceps strength,
range of motion, procedural time and complications. The results showed no differences
in any outcome measures except procedural time (single-injection; 4 ± 1.4 minutes
versus continuous; 20 ± 5.0 minutes) when comparing the single injection and
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continuous adductor blocks. The continuous group had a vascular injury at the time of
catheter insertion and one catheter accidentally dislodged from its insertion site.
Considering the similar outcome measures, extra time involved to place the catheter,
catheter cost, as well as increased risk of complications in the continuous group, they
recommended using a single-injection technique for adductor canal blockade 120. Some
studies have yielded similar results to support these findings. Turner et al. 121 found that
single-injection adductor canal blocks with multiple adjuvants (clonidine,
dexamethasone and epinephrine) provided analgesia that was equivalent to a
continuous adductor canal block up to 36 hours, though at 42 hours and beyond the
continuous group was more effective 121. Lee et al. 122 performed a randomized noninferiority study comparing the single injection and continuous adductor canal block’s
narcotic consumption at 12,24, and 48 hours post op, and failed to demonstrate that
single-injection adductor blocks were inferior to continuous blocks for narcotic
consumption at 12- and 24-hours post-op 122.
Mudumbai et al. 119 sought to compare continuous adductor canal blocks with
continuous femoral nerve blocks. The primary outcome was total ambulation distance
achieved on post-op day 1 and 2. They set the minimal clinically important difference in
ambulation distance at twice the distance in the adductor canal group compared to the
femoral nerve block group. The study was sufficiently powered (power=0.8, a= 0.05,
sample size=88) with 102 patients receiving a femoral nerve block and 66 receiving an
adductor canal block. Secondary measures included daily narcotic consumption, pain
scores and length of stay in hospital. The results for the primary outcome showed that
the adductor canal block group (37m, range 0–90m) had greater ambulation distance
than the femoral group (6m, range 0–51m) on (p=0.001). These results carried forward
to post-op day 2, with adductor canal blocks (60m, range 0-120) being superior to
femoral blocks (21m, 0-78m) (p=0.003). These results were confirmed with the use an
adjusted linear regression model. No differences in any other outcome measures were
found. This study demonstrated the significant motor sparing benefits involved with
adductor canal blocks over femoral nerve blocks 119.
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In 2018, Leung et al. 123 conducted a randomized controlled trial comparing continuous
adductor canal blocks with a control group. After exclusion and patient drop-outs, 70
patients were included in the study, with 31 patients in the control and 39 patients in the
continuous adductor canal group. They set their primary outcome as total opioid
consumption in morphine equivalents. Secondary outcome measures were VAS pain
scores measured as the area under the curve in the first 12- and 20-hours post-op,
inpatient length of stay, knee range of motion, ambulation distance, and WOMAC
scores. Blinding of the patients, as well as the outcome assessor was performed. The
study was sufficiently powered, after setting a reduction of 20mg in opioid consumption
to be clinically significant. The adductor canal block was performed under ultrasound
guidance, with a bolus of 10ml of 0.25% bupivacaine into the adductor canal, followed
by an 8ml/hr 0.125% bupivacaine infusion. The control group received a shame catheter
through a simulated procedure, without perforation of the skin with a catheter to protect
patients from unneeded harm. The study results revealed a significant increase in opioid
consumption within the control group compared to the adductor canal block group at 20
hours post-op (96.5 ± 47 mg vs. 73.9 ± 38 mg, 95% CI: −43.1 to −1.94 mg, p=0.03), but
not at 12 hours (11.9 ± 14 mg vs. 12.5 ± 15 mg, 95% CI: −6.6–7.6 mg, p=0.89). No
difference was found VAS pain scores between the two groups at 12 hours post-op
(p=0.82) but were significantly improved at 20 hours post-op for the experimental group
(adductor canal block) (p=0.04). No significant difference in length of stay was
observed, and WOMAC scores at 6 weeks were present. With paired outcomes at 3and 6-weeks post-op for range of motion, there was a significant improvement in range
of motion compared to baseline range within the continuous adductor canal group
(p=0.01). This study provided recent evidence for the efficacy of adductor canal blocks
following total knee arthroplasty 123.
Though the results with adductor canal blocks have been largely positive, there are still
several factors that inhibit their wide-spread implementation. Nerve blocks are carried
out prior to surgery and require resources such as regional block specialists, dedicated
space, and ultrasound that add to the overall treatment cost. They also come with a
host of risks, with procedure specific complications including neurovascular injury,
dense motor blockade, and catheter site complications.
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3.14

Continuous Wound Infusions:

There has been a wide variety of techniques described for directly delivering
anaesthetic to the knee joint including single-dose intraarticular injection, periarticular
infiltration where multiple sites are systematically injected around the joint prior to
wound closure, intraoperative placement of an Indwelling catheter with post-operative
intermittent bolus or continuous infusion, or a combination of these methods 82,124. The
use of indwelling catheters for wound infusion is similar to continuous perineural
catheters in that the goal of treatment is to extend the duration of effective analgesia 81.
Though there is concern in the surgical community though that indwelling catheters
surrounding a prosthesis increases the risk of infection, studies that have explored the
idea of continuous periarticular techniques have yielded variable results in terms of the
risk of infection as well as its analgesic efficacy 81,106,110,125,126
Ali et al. 110 conducted a randomized control trial comparing intraarticular catheters to
single-injection periarticular infiltration in 200 patients undergoing total knee
arthroplasty. In the experimental group (n=100), ropivacaine was infused intraarticularly,
while saline was used in the control group (n=100). Intra-operatively, both groups
received periarticular infiltration with 106mL of 2mg/ml ropivacaine, 30mg ketorolac and
0.5mg epinephrine, and thus the comparison between a single injection and continuous
method was made though this was not specifically stated. The continuous group’s
infusion consisted of 7.5mg/ml ropivacaine set a t a rate of 2mL/hr, while the control
received saline at the same rate. Their primary outcome measure was VAS score for
pain, with secondary measures being complications, length of stay in hospital, opioid
consumption, nausea and vomiting, range of movement and ability to straight leg raise.
Continuous intraarticular infusion was found to only provide a statistically significant
decrease in pain scores on post-op day one (12pm; p=0.02, 8pm p=0.03). None of the
other time points on post-op day two or three were significant, and secondary outcomes
were also insignificant. Infection was a clinically significant complication and occurred in
13 patients in the study, 11 being in the experimental group (6 superficial, 5 deep
infections) and 2 in the control (1 superficial, and 1 deep). All deep infections required
surgery for their management (4 irrigation and debridement with polyethylene
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exchange, two 2-stage revisions). Thus, continuous infusion did not extend the duration
of analgesia as significantly as they had hypothesized and carried an increased risk of
infection 110.
Sun et al. 81 performed a meta-analysis of 10 clinical trials utilizing intra-articular infusion
catheters versus placebo in 735 patients. Outcomes that were assessed were VAS
scores a rest and activity at 24, 48, and 72 hours post-op, duration of surgery, length of
stay in hospital, and complications. Their results revealed that continuous intra-articular
infusion provided statistically significant decrease in VAS pain scores at 24 hours during
rest (n=8 studies, p<0.01) and activity (n= 5 studies, p<0.01) and with activity at 48
hours (n=5 studies, p<0.01). Continuous wound infusion was also associated with a
significant decrease in nausea and vomiting (p=0.03). There were no differences in
regard to pain at rest at 48 hours as well as during rest and activity at 72 hours between
groups and length of stay was found not to be significantly different. What was
significant between groups was the rate of infection, with the continuous infusion
demonstrating an increased risk (RR 3.61; CI 95%, 1.18-8.5, p=0.02). Other
complications such as DVT were not significantly different between groups. Sun et al.
concluded that there was significant heterogeneity between studies due to the
differences in study protocol and that there was a small number of trials (n=10) included
with small sample sizes. Their results suggested that though continuous infusion
provides prolonged analgesia at 24 hours with rest and mobilization and at 48 hours
with mobilization, caution should be taken with its use until higher quality studies can
definitively determine the risks such as infection 81.
Randomized controlled trials directly comparing single-dose periarticular infiltration to
continuous intraarticular are limited within the literature. Zhang et al. 125 randomized 96
patients (80 completed the trial) to three different treatment groups, single-dose
periarticular infiltration (n=27), continuous intra-articular infusion (n=27), and saline
control group (n=26). The goal of the study was to provide evidence that continuous
wound infusion would provide a longer duration of analgesia compared to a single-dose
periarticular infiltration. The protocol called for periarticular infiltration of 150mL of
2mg/mL ropivacaine, 30mg ketorolac and 0.5mg adrenaline in both the single and

47

continuous groups. Following surgery, the continuous group received a 4mL/hr infusion
of 2mg/mL ropivacaine, and a 1.25mg/hr infusion of ketorolac for 48 hours. The primary
outcome was VAS pain scores at 2, 4, 8, 12, 16, 20, 24, 30, 36, and 48 hours, with
morphine consumption, functional recovery (maximum knee flexion at 7- and 90-days
post-op), patient satisfaction and complications all serving as secondary outcomes. The
analysis revealed that VAS scores were lower in the continuous infusion group
compared to the single-dose infiltration group and were statistically significant at rest
(p<0.05) from 8 to 48 hours post-op and during activity (p<0.05) from 16 to 48 hours
post-op. Morphine consumption was significantly higher in the single-dose infiltration
group (p<0.05). Maximum knee flexion at 7-and 90-days post-op was significantly
increased in the continuous infusion group as well (p<0.05). The incidence of nausea
and vomiting was higher in the saline control group compared to the peripheral block
groups but was not statistically significant. Complications, infection, and satisfaction
were not statistically significant between the single-injection and continuous groups. The
results of this study indicated that, as hypothesized, continuous intraarticular infusion
resulted in longer duration and superior analgesia over single- injection without a
significant increase in complications 106.

3.15

Summary:

Pain following total knee arthroplasty is a complex issue. Patients have variable
responses and anticipating their pain level can be challenging. Inadequate management
of pain following surgery can lead to delays in mobilization, discharge, and an increased
risk of complications such as deep vein thrombosis, pulmonary emboli, and pneumonia.
Multi-modal analgesia utilizing oral medications and regional anaesthesia is an effective
and safe method to manage patient’s pain following TKA, while reducing narcotic
consumption and associated adverse effects 79. Regional nerve blocks provide a variety
of benefits that include decreased opioid consumption, increased mobilization,
increased patient satisfaction, and decreased post-operative complications by
promoting ambulation 80. While single-injection techniques for these nerve blocks are
effective, their duration of analgesia does not span the early phase post-operatively
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when pain is at its worst 80,81. Continuous MSNB provides patients with effective
analgesia over a longer duration compared to single-injection techniques and improved
quadriceps function over femoral nerve blocks and epidural analgesia. This makes the
use of continuous regional methods more appealing, but unfortunately, they are not a
feasible option for all centers that perform total knee arthroplasty due to cost and
resource constraints. Novel techniques for continuous regional anaesthesia need to be
cost-effective, encourage narcotic stewardship, promote early ambulation to expedite
discharge, and be void of complications such as increased infection, dense motor
blockade, or high rate of failure. Periarticular infiltration and infusion may fulfill these
criteria. Therefore, a randomized control trial comparing its efficacy to that of MSNB
would add valuable information to the literature and perhaps a feasible option for
surgeons who don’t have access to peripheral nerve blocks for their TKA patients.
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Chapter 4

4

Objectives
The primary purpose of this randomized controlled trial is to assess whether

periarticular infiltration and infusion has a comparable time-to-discharge to that of our
previously investigated motor-sparing block technique in patients who have undergone
primary total knee arthroplasty. Our secondary objectives are to compare the two
groups analgesic quality through visual analogue scores, narcotic consumption and side
effects, and physiotherapy progress including ability to perform and range of motion
during assessments. We will investigate the rate of general and specific complications
associated with each of the study arms. We also will be collecting patient reported and
functional outcome scores using the Western Ontario McMaster Osteoarthritis Index
and Knee Society Score. Patient satisfaction and quality of life will be measured using
the Short Form 12 Survey.
We hypothesize that there will be no difference in the time to discharge between our
experimental group, periarticular infiltration and infusion, and our control, motor-sparing
nerve block following primary total knee arthroplasty. We further hypothesize that
periarticular infiltration and infusion will provide a comparable analgesic quality,
physiotherapy progress, and narcotic consumption to that of motor-sparing nerve blocks
while reducing procedure specific risks such as dense motor blockade. In doing this, we
hope to provide evidence that supports the use of periarticular infusion so that resource
constrained centers have a feasible anaesthetic option that is effective, promotes
narcotic stewardship, and has minimal risk following primary total knee arthroplasty.
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Chapter 5

5

Materials and Methods
5.1

Study Design:

This regional anaesthesia study was conducted between September 2017 and June
2018 (data collection ongoing) at London Health Sciences Centre (LHSC), University
Hospital in London, Ontario. The study design was a non-blinded, randomized control
trial with patients undergoing primary total knee arthroplasty. The study population was
extracted from the practices of three staff arthroplasty surgeons following full-board
ethical review and approval from the University of Western Ontario’s Human Subjects
Research Ethics Board.

5.2

Eligibility:

Patients were identified through the internal appointment scheduling software (App Bar),
having been scheduled for a unilateral, primary total arthroplasty procedure by one of
the three participating study surgeons at LHSC, University Hospital. Our inclusion and
exclusion criteria are listed in table 6. An initial screening for eligibility was conducted
through the available clinical documents and information provided in our center’s
electronic medical record. An inability to provide informed consent or perform study
tasks due to psychiatric illness or cognitive impairment was set as an exclusion
criterion. Patients with an allergy or intolerance to any of the pre-op, procedure related,
or post-op medications were excluded. Patients who had a documented American
Society of Anaesthesiologists (ASA) status of four from a previous surgical procedure, a
history of chronic renal failure, had an absolute contraindication to regional and/or spinal
anaesthesia, or were wheel-chair bound at the time of consultation were also excluded.
A body mass index (BMI) of greater than 45 as well as long-term narcotic
use/dependency or chronic pain (identified through the use of long-term use of potent
analgesics) made patients ineligible for study inclusion. Potential participants who were
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deemed appropriate for study involvement were approached in the preadmission clinic,
where a secondary inclusion/exclusion screening took place.
Table 6: Study Inclusion and Exclusion Criteria.
Inclusion Criteria

Exclusion Criteria

1. Adult patients ASA physical status 1-3

1. Revision arthroplasty

2. Ability to give informed consent

2. Allergy to local anesthetics and multimodal
analgesic drugs

3. No contraindications to regional techniques
3. Contraindications to spinal anaesthesia
4. Ability to perform study related tests
4. Inability to perform study related procedures
5. Scheduled for primary unilateral total knee
arthroplasty

5. Inability to give informed consent
6. Wheel chair bound
7. Pregnancy
8. Chronic renal failure
9. BMI >45
10. Chronic pain managed with long-term opioid
analgesia

5.3

Subject Recruitment:

Potential candidates who had received a consultation and booking for surgery by one of
three participating arthroplasty surgeons were initially identified and pre-screened using
our center’s electronic medical record. They were then formally approached for
recruitment and screened for exclusion criteria in the surgical pre-admission clinic within
three months of the time of surgery. Upon recruitment, several baseline patient
characteristics were collected; Age, body mass index, date of surgery, side of surgery,
previous surgery on operative knee, pre-operative diagnosis, and pre-operative
analgesic regimen.
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5.4

Randomization:

Randomization in this study was non-centralized and was performed using a random
number generation method in Microsoft excel and sealed envelope allocation technique.
Permuted block randomization into sets of 10 was utilized, with a one-to-one allocation
ratio, to avoid having an unequal distribution of the two possible procedures throughout
the trial (e.g. a span of 15 MSNB patients at the end of the trial). A third party not
involved in the assessment of outcomes performed the random number generation in
excel and group allocation was placed in a sealed envelope labelled with the
corresponding study number. No stratification was performed.

5.5

Blinding:

There was no blinding in this randomized control trial for cost and logistical reasons.
Performing two procedures, with one being a sham, would have been cost prohibitive
for the trial due to the staff, and resources needed to perform both blocks. The logistics
of implementing a sham block would have required independent anaesthesiologist
involvement to avoid unblinding the care givers and the outcome assessors to mix the
required injections and infusions. To avoid these logistical issues the study was left
unblinded.

5.6
5.6.1

Interventions:
Motor-Sparing Nerve Block Control Group:

This is a pre-operative regional anaesthetic technique that is conducted in the block
room of our center’s PACU by a staff anaesthesiologist. For the purpose of having the
ability to compare our results to part one of this two-part RCT, we utilized the same four
injection site technique12. This block differs to a standard adductor canal block in that
there are additional anaesthetic injections covering the posterior pericapsular area and
lateral femoral cutaneous nerve to provide more widespread analgesia. Prior to initial
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injection, midazolam intravenously was administered at the discretion of the
anaesthesiologist to allow for patient sedation. Patient vitals were monitored using an
electrocardiogram (ECG), pulse oximetry, and a non-invasive blood pressure monitor.
With the patient supine, positioning the operative/procedure limb involved slight flexion
of knee, with external rotation at the hip and was followed by an initial pre-procedural
scan assessing the four injection areas of interest. Sterile preparation of the leg was
done with the use of dyed chlorohexidine and sterile draping to reduce the risk of site
infection.
The initial bolus injection cocktail was prepared in the block room at the time of the
procedure. With the use of a 60 mL sterile syringe, a solution containing 0.5%
ropivacaine, 2.5 ug/ml of epinephrine, 10 mg of morphine, and 30 mg of ketorolac for a
total volume of 60mL. The solution was injected at the four following sites, intermediate
cutaneous nerve of the thigh, adductor canal (where the continuous catheter is placed),
posterior pericapsular injection, and lateral femoral cutaneous nerve to provide a
thorough regional block.

5.6.1.1

Intermediate Cutaneous Nerve of the Thigh (5mL bolus):

The first step of the procedure was the identification of neurovascular structures
in the lower limb with the use of ultrasound guidance. The femoral artery was identified
proximally at the groin and is traced along its path deep to the sartorius muscle. Once
the superior geniculate artery branch is located, the probe is turned 90 degrees and
moved superiorly again 8 to 10cm proximally and is marked as the site for injection.
What is looked for on ultrasound is the presence of a peripheral nerve laying in the
intermuscular plane between the rectus femoris and Sartorius muscles superficial to the
fascia lata. Following local skin anaesthesia with 1% lidocaine injection, an eightcentimeter Tuohy block needle is inserted at the pre-marked site, avoiding the major
neurovascular structures with the safe guidance of ultrasound. Once the needle is
superficial to the facia lata, the tip is redirected within the fascia of sartorius and 5mL of
the injection solution is delivered in the perineural area of the intermediate cutaneous
nerve of the thigh (figure 7).
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Figure 7: Ultrasound Image of the intermediate cutaneous nerve of the thigh
injection

5.6.1.2

Adductor Canal (25mL bolus):

Following the intermediate cutaneous nerve of the thigh injection, the needle is
simply redirected and advanced through the facia lata until the tip lies adjacent to the
femoral artery, deep to sartorius. A further local anaesthetic bolus of 20ml is delivered
within the adductor canal while being monitored on ultrasound using a colour doppler to
ensure proper needle tip placement and study drug administration around the femoral
artery and saphenous nerve. Prior to removal of the Tuohy needle, a flexible regional
catheter is placed using the seldinger technique, with the tip extending 3cm past the tip
of the needle. A further 5mL of study drug are delivered through the catheter for a total
of 25mL of study solution being injected into the adductor canal (figure 8). The catheter
insertion site is covered by a sterile tegaderm dressing and the free end of the catheter
is attached to an adaptor that allows for the CADD infusion line to be connected,
followed by being secured to the patient’s leg or abdomen (figure 9).
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Figure 8: Ultrasound image of the adductor canal injection

Figure 9: Continuous adductor canal catheter
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5.6.1.3

Posterior Pericapsular injection (25mL bolus)

Following the previously described steps, a pre-injection scan is utilized to mark
the site of injection and anaesthetized using lidocaine. Under ultrasound guidance, the
Tuohy needle is inserted within close proximity of the medial femoral epicondyle, and 10
cm from the knee joint line. Once confirmation of needle tip placement using colour
doppler, a bolus injection of 25mL of study drug is administered to the area between the
posterior aspect of the femur and the popliteal artery (figure 10).

Figure 10: Ultrasound Image of the posterior pericapsular injection

5.6.1.4

Lateral Femoral Cutaneous Nerve (5mL bolus)

The final injection in our study control regional block is the lateral femoral
cutaneous nerve (LFCN). It’s identified by using the ultrasound to trace sartorius back to
its origin at the anterior superior iliac spine. This is where the lacuna musculorum is
located between the origin of sartorius and tensor fascia lata and is where the LFCN
resides, and the injection site is marked and anaesthetized. The remaining 5mL of study
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solution are injected within this area following needle tip position confirmation on
ultrasound and concludes the motor sparing nerve block procedure (figure 11).

Figure 11: Ultrasound Image of the intermediate cutaneous nerve of the thigh
injection

5.6.2

Periarticular Infiltration and Infusion Experimental Group:
Periarticular Infiltration and infusion (experimental group) is a regional

anaesthetic method that is conducted intraoperatively by the surgical team. The local
infiltration injection comes in a pre-made sterile solution provided by our center’s
operating room Pyxis. The solution is provided in a standard 110ml volume of 0.5%
ropivacaine, 10mg of morphine, and 30mg of ketorolac. Toward the end of the case,
following completion of the index procedure and preparation for surgical site closure, the
surgeon injected variable volumes of infiltration anaesthetic throughout the knee joint
within the exposed soft tissues.
Following infiltration of the knee, the next step was placement of the continuous
infusion catheters, part of the periarticular infusion kit produced by Pajunk. These three,
small gauge infusion catheters are uniquely constructed being 900mm in length total,
with the most distal 75mm having 30 micro perforations 360-degrees around the
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circumference to allow equal fluid distribution to the area. The rest of the kit includes
three clamping adaptors to attach the catheters to the three-way splitter, as well as a
Tuohy needle and stylus to allow for accurate catheter placement (figure 12).

Pajunk Periarticular Catheter Kit
Contents:
1. Catheter Sheath x 3
2. Three-way Connector x 1
3. Clamping adaptors x 3
4. Tuohy Needle x 1
5. Tuohy Needle Stylus x 1
6. Infiltralong Catheter x 3
-19Gx 900mm
-30 holes/75mm

Figure 12: Pajunk Periarticular Infiltralong Catheter Kit

Catheter placement is performed with the use of the seldinger technique, using the
Tuohy needle to guide the flexible infusion catheters to their desired position. Prior to
Tuohy needle insertion the placement is finalized by marking three points superiorly,
from anterior to posterior (figure 13).
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Figure 13: Catheter placement from anterior and lateral views

5.6.2.1

Subcutaneous Catheter:

Insertion site one is positioned approximately two inches superior and two inches lateral
to the superior pole of the patella and is for placement of the subcutaneous catheter.
The Tuohy needle is inserted, and the needle tip is identified under direct visualization
within the subcutaneous space. A catheter, within its protective sheath, is fed through
and pulled to the desired length internally, leaving four black markings visible externally
(figure.8). Finally, the Tuohy needle is removed retrogradely, leaving only the catheter in
situ.
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Figure 14: Infiltralong catheter markings and perforated section

5.6.2.2

Intraarticular Catheter:

Using the same direct visualization technique utilized for the subcutaneous catheter, the
intraarticular catheter is placed at the second marked position, slightly more posterior to
the subcutaneous insertion site prior to surgical closure of the arthrotomy. The catheter
is then placed in the lateral gutter intraarticularly to allow unrestricted range of
movement and reduce the rick of the catheter becoming lodged in between the
articulating components.

5.6.2.3

Posterior Catheter Placement:

The posterior catheter uses a different method of placement, as it cannot be visualized
directly once in situ. The catheter insertion sight is dictated by firstly palpating the lateral
epicondyle of the distal femur, moving proximally past the metaphysis to the most distal
portion of the diaphysis, approximately 3 to 5cm from the epicondyle. The Tuohy needle
is inserted from lateral to medial directly perpendicular to the femoral shaft and once the
needle comes into contact with the lateral cortex, is gently redirected posterior along the
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surface of the cortex a further 2cm. Once the needle is in position, the stylus is removed
and a 10ml syringe containing sterile saline is used to initially aspirate to ensure the
needle tip is not intravascular. Once deemed safe, the saline bolus is delivered to create
space for the final catheter and the syringe is removed to allow delivery of the catheter.
Once all three catheters are in position, their exposed ends were attached to the
clamping adaptors and connected to the three-way splitter where the whole system is
primed with sterile saline. Finally, the entry sites were sealed with dermabond and
covered with a tegaderm dressing to reduce the risk of infection as well as protect the
catheters from mistakenly being dislodged from their site.

5.7

Standardization of Study Groups:

Wanting to keep the two study populations as similar as possible, a number of
standardized pre and post-surgical protocols were set. Beginning just after the time of
admission on the day of surgery, patients, with a permitting medical status, received a
pre-operative multimodal analgesic regimen consisting of 975mg Acetaminophen,
300mg Gabapentin, and 500mg Naproxen orally in the block room. The use of preoperative non-steroidal anti-inflammatories as well as neuropathic analgesics has been
shown to decrease post-operative pain and opioid consumption 69. Prior to being
transferred to the operating room for their procedure, a spinal anaesthetic was
performed by and anesthetist under titrated sedation containing 15mg of hyperbaric
bupivacaine with no intrathecal opioids. The initial bolus in both groups were also
standardized containing 0.5% ropivacaine, 30mg Ketorolac, and 10mg of morphine,
being delivered through either ultrasound guided injections pre-operatively in the MSNB
group or through periarticular infiltration in the experimental group intraoperatively.
150mcg of Epinephrine were also added to the MSNB injection as per protocol in our
previous study, where it was not included in the knee infiltration cocktail due to the risk
of contamination of the previously described standard infiltration solution that is readily
available in our operating room.
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In terms of intra-operative surgical standardization, all patients underwent a primary
total knee arthroplasty using one of two implant options; Depuy Attune or Stryker
Triathlon. Cases were performed with the use of a tourniquet for a bloodless technique
and the addition of patellar resurfacing during the procedure was left to the surgeon’s
judgement.
Post-operatively, the basal infusion in either group was commenced in the postoperative care unit with the use of a continuous ambulatory delivery device (CADD
pump). The infusion drug administered was 0.2% ropivacaine, set at a basal rate of 8
milliliters per hour (lock-out of 8.1 milliliters), with the option of a patient-controlled bolus
being removed. For breakthrough or uncontrolled post-operative pain, a standardized
multimodal analgesic order-set consisting of 650mg Acetaminophen Q6h, Naproxen
500mg Q12h, Tramadol 50mg Q4h PRN, Hydromorphone Tablets 2-4mg Q3h PRN,
and Hydromorphone Subcutaneous Injection 1mg Q3h PRN. Catheter removal was
contingent on the patient meeting criteria for discharge, with readiness for discharge
being dictated by our center’s standard protocol.
A communication order made in the study’s EMR order-set stated the Hold
catheter or MSNB infusion at 6am post-operative day 2 or day of discharge, whichever
comes sooner.” This allowed for a more accurate assessment of pain prior to regional
block removal and for possible post-operative day one discharge in patients who
progressed through the post-op milestones more rapidly. Upon meeting criteria for
discharge, the block catheters were then removed.
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5.8

Outcome Measures:

The following outcomes were measured at various time-points depending on the type of
data collected. Figure 15 is a time-line displaying the outcomes collected at various
time-points.

Figure 15: Timeline of outcome data collection

5.8.1

Primary Outcome Measure:

The primary outcome measure was set as time-to-discharge in this study. This was
defined as the time at admission to the time of discharge. There are a variety of factors
that can delay patient’s early discharge following a total knee replacement. Poor pain
control is a common cause to delay discharge but can also be a major component in
other post-operative issues. Inadequate analgesia can lead to an increase in opioid
related complications (Ileus/constipation, nausea/vomiting, delirium, sedation,
respiratory depression), inability to perform physiotherapy exercises and milestones
required for discharge, and cause patient to be unwilling to go home. All known
complications suffered by inpatients were recorded to both ensure there weren’t any
major adverse events associated with one of the groups, and to be taken into
consideration at the time of final analysis.
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Readiness for discharge is dictated by our center’s discharge protocol found below. The
care team, specifically the attending surgeon/team resident and physiotherapist, assess
and determine if patients have satisfactorily met these criteria.
Discharge Criteria:
1. Patient able to complete daily tasks such as get in and out of a chair or bed, get
off and on the toilet, walk a suitable distance (30m) with proper walking aids
without a time limit, and navigate an acceptable number of stairs.
2. Have no medical or surgical complications including urinary catheterization or
need for blood transfusion
3. Acceptable pain relief (NRS = 5/10) without any need for intravenous analgesics.
4. No nausea/ vomiting; generalized weakness or dizziness.
5. Knee flexion of 900 is optional but preferred.
With these criteria, an effective regional anaesthetic technique must work to expedite
the post-operative process by treating patient’s pain, while reducing the risk of
potentially discharge delaying complications and be cost-effective. With the everincreasing cost of healthcare, exploring possible care options that reduce the inpatient
stay of patients is important to the future of patient management following total knee
arthroplasty.

5.8.2

Secondary Outcome Measures:

Numerous secondary outcomes were measured throughout the study period. This
allowed for collection of possible confounders that could affect a patient’s time to
discharge, as well as ensure no significant functional differences occurred between the
two groups.

5.8.2.1

Numeric Pain Rating Scale (NPRS):

A numeric pain scale was utilized in the study to assess patient’s subjective pain levels
both at rest and during activity. Activity was described as any major movement of or
weightbearing on operative leg. The 11-point scale, measuring 0-10 (10 being the worst
pain ever experienced) was assessed using a visual analogue scale (VAS). This model

65

has been verified by Williamson et al.127 and was found to be highly sensitive, reliable,
and easy to obtain. Pre-operative baseline scores were collected on the day of surgery
before commencement of the spinal anaesthetic. VAS scores were collected postoperatively at six hours, and then again at 9am and 2pm during each inpatient postoperative day by a study assessor. Upon discharge, patients were instructed on the use
of a pain dairy to chronical their own scores for four more post-discharge days.

5.8.2.2

Narcotic Consumption:

Narcotic consumption post-operatively was collected at six hours, 9 am and 2pm of
each inpatient post-operative day, and during the four days post-discharge by patients
through the pain dairy. The time, dose and frequency were recorded from the
medication administration record available in the our EMR, as well as from the patient’s
pain diary. All narcotic medications were converted to morphine equivalence for
comparison between the two groups.

5.8.2.3

Physiotherapy status:

Physiotherapy progress was recorded at the time of each assessment during the
patient’s inpatient stay. Patient’s ability to perform physiotherapy and complications that
inhibited their ability were documented. Progress was measured through range of
movement by the staff physiotherapists. These measurements are involved in the
criteria for discharge and can be affected by the efficacy of a patient’s analgesic
modality.

5.8.2.4

Complications/Adverse Events:

All complications, regardless of being directly, indirectly or not contributable to the
surgical procedure were recorded. Information documented regarding the complication
included the diagnosis, date, treatment administered, whether a delay in discharge
occurred because of it, and the discharge day following successful management.
Complications being monitored include the rates of myocardial infarction, deep venous
thrombosis, pulmonary emboli, paralytic ileus, gastrointestinal bleed, new onset renal
dysfunction, wound infection, as well as procedure specific complications such as dense
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motor block in the MSNB group. This will allow us to control for a possible confounder in
the final analysis.

5.8.2.5

Side Effects:

At the time of each inpatient visit as well as during assessment time points in the pain
diary, side effects that were collected included the presence of nausea or vomiting as
well as sedation. Patients used a five-point evaluation scale for nausea with none, mild,
moderate, severe, extreme as options. For sedation, a 5-point scale of 0-5 was utilized,
with 0 being not sedated, to 5 being nearly unable to stay awake.

5.8.2.6

Vital Sign Data:

During in-patient data collection visits, research staff collected data pertaining to the
most recent vital signs recorded by the nursing staff, specifically looking at respiratory
rate, pulse oximetry as well as whether the patient was breathing on supplementary
oxygen or room air. This was to assess for the presence of respiratory depression
associated with narcotic medications being used for breakthrough pain in the postoperative multimodal analgesic order set.

5.8.3

Functional outcomes:

Functional outcomes following total joint arthroplasty are an important and expected
measurement in trials. A procedure that causes a significant deviation in the expected
functional outcomes of patients should not be considered for implementation into
practice.

5.8.3.1

WOMAC:

The Western and McMaster Universities Osteoarthritis Index is a patient reported
outcome measure that assesses symptoms and physical disability caused by
osteoarthritis of the hip or knee. There are a number of tailored questions that are
designed to evaluate three specific categories including pain (five questions, score 020), stiffness (two questions, score 0-8), and subjective physical function (17 questions,
score 0-68). The three scores create individual numeric values for each of the three
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dimensions as well as a total score that correlates with the severity of the patient’s
symptoms. The version used in our study is called Likert version, which uses a scale of
none (0), mild (1), moderate (2), severe (3), and extreme (4), with a higher score
indicating a worse symptom/functional state. The WOMAC also allows healthcare
providers a means of evaluating clinically important changes in health status over time
following administration of an intervention128.
The WOMAC is a validated tool that when applied to total knee replacement trials, can
provide reliable and sensitive outcome data. A literature review of 43 articles conducted
by McConnell et al.129 found that the internal consistency for pain, stiffness, and
physical function measured 0.86, 0.90, and 0.95 respectively.
In our study, it was decided a baseline WOMAC score would be collected at the preadmission appointment, with post-operative reassessments occurring at the 6-week and
3-month follow-up visits.

5.8.3.2

The New Knee Society Score:

The new Knee Society Score (KSS) is a combined subjective (patient) and objective
(clinician) outcome measurement tool. The original Knee Society Clinical Rating Tool,
developed in 1989, allowed for the objective measurement by healthcare providers of a
patient’s functional abilities both pre and post-operatively following TKA. The validity of
the original tool diminished over time with the greater importance of patient’s
expectations, demands, and functional requirements being realized130.
The new Knee Society Scoring system was developed and validated in 2011 to take
these considerations and incorporate them into a more contemporary model and
includes both a pre-operative and post-operative version. A combination of patient
reported outcomes as well as a physical and radiographic assessment carried out by
the clinician. For the functional component of the survey scores are created in four
specific dimensions including symptoms, satisfaction, expectations, and functional
activity130.
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The objective score and purely clinician assessed component includes physical
examination findings, and radiographic components. These questions include a VAS
pain score, range of movement, presence of flexion contracture (points deducted
depending on degree), presence of extension lag (points deducted depending on
degree), ligamentous stability, and radiographic alignment.

5.8.3.3

SF-12 Health Survey:

The Short Form Survey 12, or SF-12, is a condensed version of SF-36 health survey
that aims to evaluate a patient’s personal view on the status of their over-all health, both
mental and physical. The SF-12 is a validated, reliable and responsive patient reported
outcome measure131. The content of the questions covers physical function (two
questions), bodily pain (one question), general health perceptions (one question), vitality
(one question), social functioning (one question), emotional problems interfering with
social activities (two questions), and finally, general mental health (two questions)131.
The scores from these questions are then applied to an overall SF-12 physical and SF12 mental health scores, with a range of zero (worst possible health state) to 100 (best
possible health state).
Again, a baseline score was taken at the pre-admission appointment, with postoperative values coming from the 6-week and 3-month follow-up visits.

5.9

Sample Size:

In a case study conducted by Kerr and Kohan et al.101 involving 325 patients, it was
found that the overnight discharge rate with local wound infiltration was 71%. We expect
a 30% improvement in the overnight discharge rates for patients who receive a motor
sparing nerve block.
A formal equality sample size calculation was performed with a two- sided alpha error
rate of 0.05, with statistical power being set at 80%. e
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5.10

Data Analysis:

We analyzed all data from patients with an intention to treat analysis using SPSS
Version.24 (IBM Corp, Armonk, NY). For patient demographic characteristics, we
employed the use of descriptive statistics, comparing the means and reporting the
standard deviations for continuous variables (age, height, weight, BMI), and proportions
for nominal variables132.
For the analysis of our primary outcome, time to discharge, we used a Mann-Whitney U
Analysis with Bonferroni correction due to the inherent lack of data normality. The
dependent variable was time to discharge and the group allocation (MSNB or LIA and
infusion) was the independent variable. For secondary outcomes, we utilized a
multivariate analysis of covariance (MANCOVA) to compare VAS pain scores at rest
and activity at the various data collection time points. The dependent variable was VAS
score, the group allocation (MSNB or LIA and infusion) the independent variable, with
baseline VAS scores (rest and activity) served as covariates132,133.
Multivariate analysis of variance (MANOVA) was performed for narcotic consumption
(in morphine equivalence), respiratory rate and oxygen saturation to compare the
groups at each inpatient time point. An analysis of covariance (ANCOVA) was
performed for patient reported outcome measures (SF-12, WOMAC, KSS), as well as
physiotherapy range of movement. Baseline WOMAC, SF-12, KSS scores, and
preoperative range of movement were used as covariates respectively. If data was
found to be not normally distributed, we used a Mann-Whitney U statistical test to
compare the two groups, and a Bonferroni correction was utilized to correct for multiple
comparisons132.
We set significance at p<0.05 and reported the unadjusted mean with 95% confidence
intervals (CI) in figures. In the tables and text, the adjusted mean (means adjusted to
the presence of the covariate) with standard error (SE) was stated as well as the
adjusted mean difference with 95% CI. For missing data points, the last outcome carried
forward method was utilized132.
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Chapter 6

6

Results
6.1

Participant Flow

Following pre-screening using our hospital’s electronic medical record, patients were
approached through the preadmission clinic prior to surgery to be assessed for study
eligibility. Participant flow through the study is demonstrated in Figure 16. From October
2017 to May 2018, a total of 422 patients were screened for the study. Of this group, 72
patients were randomized, with 75% (n=54) successfully enrolled in the trial. In the
motor sparing nerve block group (MSNB), there were 29 patients and in periarticular
Infiltration and infusion group (LIA and infusion) there were 25. Demographic data is
provided in Table 7. All 54 patients had inpatient VAS, physiotherapy, and narcotic
consumption data, with 42 patients reaching the end of the trial (3-months) at the time of
analysis. Study power was not achieved, and the following results are from an interim
analysis.
Patient ineligibility was determined utilizing previous medical documentation or during
the preadmission interview. The most common reasons for exclusion were chronic pain
and pre-operative narcotic use (n=78), enrollment in another study (n=65), declining to
participate (n=45) and BMI >45 (n=36).
Twenty-five percent (n=18) of the enrolled patients were excluded following
randomization. Reasons included violation of study protocol (n=1), undisclosed allergy
to a study drug (n=1), non-disclosure of pre-operative narcotic abuse (n=1) and
contraindicated to MSNB due to recent anticoagulation (n=1). Other reasons were
changed date of surgery (n=1), failure of block catheter placement (n=2), two patients
dropped out of the study prior to surgery, and unknown chronic renal impairment (n=2).
Seven patients were unable to participate in the study due to an unforeseen nationwide
supply shortage of ropivacaine, resulting in a study hiatus. No study participants
required conversion from spinal anaesthetic to general anaesthetic intraoperatively.
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Figure 16: Participant flow through the study
Table 7: Patient Demographics
Characteristic

Motor Sparing Knee Block
(n=29)

Periarticular Infiltration and
Infusion (n=25)

Male, n (%)

n= 14 (48%)

n= 13 (52%)

Mean Age ± SD, y

68 ± 8.37

65 ± 9.56

Mean Height ±SD, cm

169 ± 10.07

169 ± 10.66

Mean Weight ± SD, kg

90 ± 18.06

91 ± 18.55

Mean BMI ± SD, kg/m2

31.85 ± 5.42

31.96 ± 6.02

Operative Knee, Right

n=14 (48%)

n=11 (44%)

ASA Status
One
Two
Three

Mean= 2.55 ± 0.50

Mean= 2.32 ± 0.56
n=1 (4%)

n=13 (45%)

n=15 (60%)

n=16 (55%)

n=9 (36%)
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Pre-Operative Diagnosis
Osteoarthritis

n=28 (97%)

n=24 (96%)

Inflammatory

n= 1 (3%)

n= 1 (4%)

n=6 (21%)

n=12 (48%)

n=2

n=11

n=2

n=1

Previous Surgery on ipsilateral knee
(total)
Arthroscopy
Osteotomy
Ligament reconstruction
n=2

SD = standard deviation, BMI = body mass index, ASA = American Society of
Anaesthesiologists physical status classification system

6.2
6.2.1

Primary Outcome Measure:
Time to Discharge from Hospital:

There were no statistically significant differences in the times to discharge between the
motor sparing nerve block and the periarticular infiltration and infusion groups (p= 0.47).
The mean time to discharge for the MSNB group was 2.57 days (SD ± 1.0), while the
LIA and infusion group was 2.5 days (SD ± 1.25). Both groups had similar mean time to
discharge and are both skewed towards a short duration in hospital as demonstrated in
the histograms below (figure 17).
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Figure 17: Distribution of time to discharge from hospital for MSNB and
periarticular infiltration and infusion
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6.3
6.3.1

Secondary Outcome Measures:
Visual Analogue Scale Pain Scores

Visual analogue scale (VAS) pain scores were collected for both groups at each
inpatient time point as well as following discharge through the pain diaries. VAS scores
at rest as well as with activity were documented individually. Data was collected at six
hours post-op and for six post-operative days, twice daily, for a total of 13 collection
points.

6.3.2

Visual Analogue Scale at Rest:

Using the pillai’s trace test with MANCOVA analysis, there was not a significant
difference for VAS scores at rest between the two groups, MSNB and LIA, when
controlling for pre-operative VAS rest scores (V=0.3, F (13,39) = 1.28, p=.266). Table 8
displays the adjusted means for both groups at each time point. Separate univariate
ANCOVAs did show a significant difference in VAS rest pain scores between the
adjusted means at 6 hours post-op (F (2, 51) = 4.46, p= 0.016) with the MSNB group
having superior analgesia less. No other time points were statistically significant. The
covariate for pre-op VAS score at rest did not have a significant effect on the outcome
(post-op pain at rest) V=0.27, F (13, 39) = 10.9, p=0.39. Figure 18 graphically displays
the unadjusted VAS score means over the assessment period.
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Table 8:VAS scores at rest (adjusted means, bold indicates significant time
points)
Time Point Postop

MSNB mean ±
SE

LIA mean ± SE

Adjusted Mean
difference (95%
CI)

p-value

6 hours

2.09 ± 0.45

3.97 ± 0.48

-1.88 (-3.21 to .551

p=0.007

POD1 9am

3.30 ± 0.42

4.09 ± 0.45

-0.78 (-2.03 to
0.47)

p=0.21

POD1 2pm

3.02 ± 0.39

3.66 ± 0.41

-0.65 (-1.80 to
0.51)

p=0.26

POD2 9am

2.71 ± 0.33

1.99 ± 0.36

0.79 (-0.19 to
1.78)

p=0.11

POD2 2pm

2.81 ± 0.35

2.14 ± 0.38

0.67 (-0.37 to
1.72)

p=0.20

POD3 9am

2.79 ± 0.36

2.64 ± 0.39

0.15 (-0.84 to
1.15)

p=0.75

POD3 2pm

2.76 ± 0.36

2.61 ± 0.39

0.15 (-0.912 to
1.21)

p=0.77

POD4 9am

2.67 ± 0.41

2.67 ± 0.44

0.00 (-0.1.6 to
1.07)

p=0.99

POD4 2pm

2.83 ± 0.38

2.76 ± 0.41

0.06 (-0.15 to
1.28)

p=0.91

POD5 9am

2.81 ± 0.37

2.46 ± 0.40

0.36 (-0.78 to
1.48)

p=0.52

POD5 2pm

3.05 ± 0.37

2.47 ± 0.40

0.62 (-0.89 to
1.1)

p=0.26

POD6 9am

2.75 ± 0.34

2.85 ± 0.36

-0.11 (-1.1 to
0.88)

p=0.83

POD6 2pm

2.79 ± 0.34

2.29 ± 0.36

0.50 (-0.5 to 1.5)

p=0.31

77

10
9
Pain Score (0-10)

8
7
6
5
4
3
2
1
0
Pre-op

6hr

9am

2pm

POD1

9am

2pm

9am

2pm

POD2

9am

2pm

POD3
POD4
Post-Operative Time Points
Motor Sparing Block
Infiltration

9am

2pm

POD5

9am

2pm

POD6

Figure 18: VAS scores at rest between MSNB and LIA and infusion groups
(unadjusted means)

6.3.3

Visual Analogue Scale with Activity:

Following MANCOVA analysis and pillai’s trace test, there was not an overall significant
treatment effect between MSNB and periarticular infiltration, when controlling for preoperative activity VAS pain scores on the reported VAS for pain during activity (V= 0.37,
F (13,39) = 1.76, p=0.086). Table 9 displays the adjusted means for both groups at
each time point. Separate univariate ANCOVAs did show a significant difference in VAS
activity scores between the adjusted means at three time points; 6 hours post-op (F (2,
51) = 9.03, p< 0.001); 2pm Post-op day (POD) 1 (F (2, 51) = 8.59, p= 0.001); 9am POD
2 (F (2,51) = 4.24, p= 0.02). MSNB had superior analgesia at 6 hours post-op and 2pm
POD 1, but LIA and infusion was superior at 9am POD 2. No other time points were
statistically significant. The covariate for pre-op VAS score during activity did have a
significant effect on the post-op VAS scores (V=0.40, F (13, 39) = 2.05, p=0.04). Figure
19 graphically displays the unadjusted means over the assessment period.
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Table 9: VAS scores with Activity (adjusted means, bold indicates significant time
points)
Time Point Post-

MSNB mean ± SE

op

LIA and Infusion

Adjusted Mean

mean ± SE

difference (95%

p-value

CI)
6 hours

3.34 ± 0.46

5.87 ± 0.49

-2.48 (-3.84 to -

p=0.001

1.126)
POD1 9am

6.29 ± 0.41

7.03 ± 0.44

-0.74 (-0.48 to

p=0.22

1.95)
POD1 2pm

5.97 ± 0.37

7.23 ± 0.40

-1.27 (-2.35 to -

p=0.02

0.85)
POD2 9am

5.84 ± 0.35

5.35 ± 0.38

0.49 (-0.55 to

p=0.34

1.53)
POD2 2pm

5.29 ± 0.43

5.27 ± 0.46

0.02 (-1.24 to

p=0.9

1.27)
POD3 9am

5.34 ± 0.44

5.66 ± 0.48

0.08 (-1.23 to

p=0.90

1.38)
POD3 2pm

5.36 ± 4.49

5.74 ± 0.47

-0.39 (-1.68 to

p=0.56

0.92)
POD4 9am

5.02 ± 0.47

5.34 ± 0.50

-0.31 (-1.70 to

p=0.65

1.08)
POD4 2pm

5.17 ± 0.49

5.13 ± 0.53

0.04 (-1.38 to

p=0.95

1.49)
POD5 9am

5.46 ± 0.48

5.12 ± 0.51

0.32 (-1.08 to

p=0.64

1.72)
POD5 2pm

5.59 ± 0.49

5.08 ± 0.52

0.46 (-0.97 to
1.89)

p=0.51
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POD6 9am

5.24 ± 0.49

5.20 ± 0.52

0.04 (-1.37 to

p=0.95

1.45)
POD6 2pm

4.93 ± 0.47

5. 04 ± 0.51

-0.11 (-1.50 to

p=0.87

1.27)
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Figure 19: VAS scores during activity between MSNB and LIA and infusion
groups (unadjusted means)
Below, Figures 20 and 21 combine the rest and activity VAS unadjusted means
for each group to graphically display the magnitude of difference between the two
scores at each time point.
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Figure 20: MSNB VAS scores at rest and during activity (unadjusted means)
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Figure 21: LIA and Infusion VAS scores at rest and during activity (unadjusted
means)
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6.3.4

Narcotic Consumption:

Inpatient narcotic consumption between time points was converted to morphine
equivalence and the groups were compared (figure 22). There was no overall
statistically significant difference in narcotic consumption between the two groups
(pillai’s trace V=0.073, F (5, 48) = 0.76, p= 0.59). There were also no significant
differences at any of the time points between group unadjusted means (Table 10).
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Figure 22: Morphine Equivalence (unadjusted means)
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Table 10: Narcotic consumption in morphine equivalents (unadjusted means)
Time Point Post-

MSNB mean ± SE

LIA and Infusion mean ± SE

op
2.66 ± 1.17
6 hours

4.64 ± 1.26

POD1 9am

23.66 ± 4.50

32.72 ± 4.85

POD1 2pm

12.00 ± 1.98

15.84 ± 2.13

POD2 9am

34.621 ± 5.14

45.440 ± 5.54

POD2 2pm

20.310 ± 4.35

25.200 ± 4.69

6.3.5
6.3.5.1

Side Effects:
Nausea:

Nausea is a common side effect as a result of narcotic use and was quantitatively
assessed using a 0-4 numeric scale (0=none, 1=mild, 2=moderate, 3=severe, 4=
extreme). There was no significant overall difference in nausea scores between
treatment groups during the 6-day assessment period (p=0.21) (figure 23).
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Figure 23: Nausea scores (unadjusted means)

6.3.6

Inpatient Respiratory Rate and Oxygen Saturation:

Patient vitals were collected at each post-operative timepoint to ensure there were no
significant respiratory side effects because of large quantities of narcotic medications.
There were no statistically significant differences in respiratory rate (p=0.54) and oxygen
saturation (p=0.67) between groups during the in-patient stay.

6.3.7

Physiotherapy:

While patients were in hospital, the ability to perform physiotherapy was noted by
documenting the time point they had successfully performed physiotherapy by. There
was no statistically significant difference (p=0.49) between groups in their ability to
begin physiotherapy (means ± SD, time point; MSNB 2.07 ± 1.13, LIA and infusion 1.96
± 0.98).
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Range of movement (ROM) post-op was analyzed using two different outcomes, one
being first ROM measured during physiotherapy and the other best achieved ROM
while in hospital. Pre-operative ROM served as the covariate to control for baseline
differences. There was no statistically significant difference in first measured ROM
between groups post-operatively (F (2,51) = 1.51, p= 0.23). There also was no
significant difference between groups comparing best achieved ROM while in hospital
(F (2, 51) = 1.98, p= 0.15).

6.3.8

Two-week Follow-up Data:

6.3.8.1

Vas Pain Scores:

VAS rest and activity scores were collected at the 2-week post-operative visit. The preoperative VAS scores were used as a covariate during analysis. There were no
statistically significant differences in VAS scores at two weeks post-op during rest (F (2,
51) = 0.535, p= 0.59) or activity (F (2, 51) = 1.51, p= 0.23). Table 4 displays adjusted
means to the covariate for each group.
Table 11: VAS score adjusted means at two weeks
VAS Score

MSNB mean ± SE

LIA and Infusion mean ± SE

Rest

2.39 ± 0.36

2.15 ± 0.39

Activity

4.12 ± 0.40

4.1 ± 0.44

6.3.8.2

Range of Movement:

There was no statistically significant difference in range of movement between groups
at 2-weeks post-op after controlling for pre-operative ROM (F (2, 51) = 1.41, p = 0.25).
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6.3.9

Patient Reported Outcome Measures:
Patient reported outcome measures including 12-item short-form survey (SF-12),

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Knee
Society Score (KSS) were collected pre-op and again at 6-weeks and 3-months postop. Data that was found to be not normally distributed prior to analysis included pre-op
SF-12, Objective Knee Indicators, 6-week KSS symptoms, and 3-month KSS
symptoms, and Objective Knee Indicators. Only one data point was found to be
statistically significant. The KSS Expectations subsection was statistically significant
between groups at the 6-week post-operative assessment (F (2, 51)= 4.78, p = 0.012).
All other outcome measures at both the 6-week and 3-month post-operative timepoints
were not significant. The adjusted means are reported below for SF-12 (table 12),
WOMAC (table 13), and KSS (table 14).
Table 12: SF-12 patient reported outcome data
Time Point

Pre-op

SF-12

MSNB mean ±

LIA and Infusion

Sig.

Component

SE

mean ± SE

SF-12 Mental

55.60 ± 1.50

52.79 ± 1.88

p= 0.07

SF-12

33.73 ± 1.91

36.91 ± 1.80

p= 0.20

SF-12 Mental

53.49 ± 1.6

53.90 ± 1.72

p=0.86

SF-12

33.80 ± 1.51

35.44 ± 1.5

p=0.43

SF-12 Mental

56.19 ± 1.34

54.79 ± 1.44

p=0.48

SF-12

39.86 ± 1.65

41.45 ± 1.78

p= 0.548

Physical
6-week

Physical
3-month

Physical
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Table 13: WOMAC Total patient reported outcome data
Time Point

MSNB mean ±

LIA and Infusion

Sig.

SE

mean ± SE

Pre-op

51.42 ± 3.64

56.63 ± 3.69

p=0.277

6-week

67.23 ± 2.20

65.01 ± 2.37

p=0.499

3-month

73.23 ± 2.65

71.40 ± 2.85

p= 0.64

Table 14:KSS patient reported outcome data (bold indicates significant time
point)
Time Point

Pre-op

KSS

MSNB mean ±

LIA and Infusion

Sig.

Component

SE

mean ± SE

Symptoms

15.52 ± 0.80

18.04 ± 1.07

p= 0.13

Expectations

13.89 ± 0.26

12.56 ± 0.61

p= 0.06

Satisfaction

15.45 ± 1.56

19.48 ± 1.79

p=0.07

Functional

38.69 ± 3.12

42.0 ± 3.23

p= 0.58

35.89 ± 3.38

43.64 ± 4.21

p=0.54

Symptoms

21.66 ± 0.86

21.88 ± 4.74

p=0.48

Expectations

9.81 ± 0.52

9.62 ± 0.56

p = 0.01

Satisfaction

24.785 ± 1.47

25.13 ± 1.5

p=0.88

Activity
Objective
Knee
Indicators
6-week
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Functional

48.85 ± 2.81

52.69 ± 3.03

p= 0.36

63.22 ± 1.81

65.30 ± 1.95

p= 0.443

Symptoms

22.97 ± 0.873

22.88 ± 0.74

p=0.30

Expectations

10.15 ± 0.58

10.11 ± 0.567

p=0.15

Satisfaction

30.08 ± 1.59

27.38 ± 1.71

p= 0.26

Functional

61.07 ± 2.90

61.15 ± 3.13

p= 0.98

64.20 ± 2.99

65.92 ± 2.16

p=0.18

Activity
Objective
Knee
Indicators
3-month

Activity
Objective
Knee
Indicators

6.3.10

Adverse Events and Complications:

Throughout the course of the trial adverse events and complications were
recorded during patient’s in-hospital stay and follow-up interviews. There was a total of
eight significant adverse events that caused a delay in discharge, three in the MSNB
group and five in the LIA and infusion group (table 15).
Table 15: Significant adverse events during study period
Complication

Group

Treatment

Delay in Discharge

Foot drop

MSNB

Block cessation

1 day

Foot drop

LIA and Infusion

Block cessation

1 day

Quadriceps

MSNB

Block cessation

2 days

Weakness
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Quadriceps

LIA and Infusion

Block cessation

4 days

MSNB

Therapeutic Anticoagulation

3 days

LIA and Infusion

Spontaneous drainage, no

No delay, noted at two-

septic arthritis

week follow-up

Block, cessation and supportive

No delay

Weakness
Pulmonary
Embolism
Catheter Site
Abscess
Anaesthetic

LIA and Infusion

Toxicity
Urinary

management
LIA and Infusion

Supportive management

No delay

Retention

Inadequate analgesia was the cause for delayed discharge in three MSNB patients
(range, 1-2 days), and two LIA and infiltration patients (range, 1-4 days). Other
complications were less debilitating and did not inhibit discharge. In the MSNB group,
one patient’s block catheter occluded with blood, one patient’s catheter was accidentally
dislodged from the entry site during physiotherapy, and one patent’s catheter leaked
significantly. The management for each of these was early block removal and
conversion to oral analgesia. In the LIA and infusion group 14 patients had at least one
catheter occlude with blood, three patients had significant leaking at catheter sites, and
two patients had accidental dislodgment of one of the catheters.
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Chapter 7

7

Discussion

The purpose of this randomized control trial was to assess whether periarticular
infiltration and infusion has a comparable time-to-discharge, analgesic quality, and
complication rate to motor-sparing nerve blocks (MSNB) in patients who have
undergone primary total knee arthroplasty. Interim analysis demonstrated no significant
difference between the two groups in terms of the primary outcome of time to discharge
from hospital (p=0.47). The mean time to discharge for MSNB and periarticular
infiltration and infusion was 2.57 days (SD ± 1.0) and 2.5 days (SD ± 1.25) respectively.
Current studies comparing continuous peripheral nerve blocks with intra-articular
infusion are limited, but the literature supports this finding. Beausang et al. randomized
96 patients to two study groups, continuous adductor canal block (n=50) and
intraarticular catheter infusion (N=46) 134. They failed to demonstrate any significant
difference between groups for length of stay in hospital (mean: 1.8 days for both
groups). In a meta-analysis of 10 studies involving intra-articular catheters, Sun et al.
found no statistical difference in the length of stay length of stay compared to placebo
81

.

Regarding our secondary outcome measures, there were no overall significant
differences in visual analogue scale (VAS) pain scores at rest or with activity. Similar to
our previous study 12, MSNB provided a significant decrease in early pain scores.
MSNB provided superior analgesia at 6-hours post-op during rest and activity as well as
the afternoon of post-op day one during activity. On the morning of post-op day 2, there
was a significant difference in pain scores during activity that in contrast favored
periarticular infiltration and infusion. Peripheral nerve block studies are notoriously
difficult to compare, as their results rely heavily on a number of variables including
insertional technique, block location, anaesthetic drug choice, concentration and
infusion rate, as well as analgesic adjuncts 81,93. Despite this, Beausang et al. found a
similar result in that their adductor canal block group had significantly lower pain scores
(3.60 ± 2.2 vs 4.38 ± 2.4, p= 0.02) early on prior to activity (physiotherapy) compared to
continuous intraarticular infusion. Following the first data collection point, there were no
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statistically significant differences in pain scores during and after activity 134. In our
previous study, MSNB also had statistically significant lower pain scores early on at 2and 4-hours post-op with activity, and 2 hours post-op at rest 12.
The MSNB in our study is a modification of a standard adductor canal block to provide
more posterior and lateral knee anaesthetic coverage as the knee is innervated by both
the lumbar plexus (femoral and obturator nerves anterolaterally) and sacral plexus
(sciatic nerve posteriorly) 22,135. Adductor canal blocks have shown to be a reliable
method of analgesia following total knee arthroplasty and provide the option of an
indwelling catheter to prolong the block effect and decrease narcotic consumption
24,80,90,136,137

. Additionally, they have less risk of inhibiting quadriceps motor function and

promote early ambulation in comparison to other more proximal regional methods such
as epidural catheters and femoral nerve blocks 15,90,93,118. With MSNB, placement of a
perineural indwelling catheter provides the option to prolong the anaesthetic effect of
the block through bolus or continuous dosing of local anaesthetic 80. A substantial
amount of evidence highlighting the potential benefits of continuous blocks exists, but
few studies have compared single-injection adductor canal blocks versus a continuous
technique directly.
Shah et al. performed a randomized control trial comparing single-injection versus
continuous adductor canal blocks analgesic efficacy, early patient ambulation and
functional recovery, as well as opioid consumption 135. They found that the continuous
group had statistically significant lower VAS pain scores at 4, 8 ,12, and 24 hours post
op (p<0.001). There was also a significant difference in pain scores favoring the
continuous block group at rest and activity on post-op day 1 and 2 (p<0.001). Two
patients in the single-injection group required rescue opioid analgesia and none in the
continuous group, which was consistent with other studies 92. The results supported the
notion that continuous infusion extended the effect of peripheral analgesia compared to
a single- injection technique.
One would expect this outcome, as intuitively, having the ability to deliver more
anaesthetic over time should yield a longer duration of analgesia. However, the results
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comparing single-shot and continuous adductor canal blocks have been inconsistent.
Zhang et al. performed a randomized, placebo-controlled trial comparing single-shot
adductor canal block, continuous adductor canal block and a saline control group 120.
The primary outcome was visual analogue scale for pain during activity. When
comparing the two adductor canal block groups, single- injection versus continuous,
they found no differences in any outcome measures except procedural time (singleinjection; 4 ± 1.4 minutes versus continuous; 20 ± 5.0 minutes) and complications. The
continuous group had a vascular injury at the time of catheter insertion and one catheter
accidentally dislodged from its insertion site. Considering the similar outcome
measures, extra time involved to place the catheter, catheter cost, as well as increased
risk of complications in the continuous group, they recommended using a singleinjection technique for adductor canal blockade 120.
Bingham et al. performed a systematic review and meta-analysis of randomized
controlled trials comparing single-injection to continuous peripheral nerve block
techniques. They extracted data from 21 trials concerning pain scores, narcotic
consumption, satisfaction and adverse effects. What was found was continuous
peripheral blocks provided a significant decrease in pain scores on post-operative day
zero (day of surgery) (p=0.005), one (p<0.001) and two (p<0.001). Patients who had a
continuous block had significantly decreased narcotic intake and nausea symptoms and
had higher overall patient satisfaction scores 92.
Though continuous techniques possess these appealing qualities, there are still several
factors that inhibit their wide-spread implementation. Nerve blocks are carried out prior
to surgery and require resources such as regional block specialists, dedicated space,
and ultrasound that add to the overall treatment cost. It isn’t without its risks either, with
procedure specific complications including nerve injury, dense motor blockade, and
catheter site complications 89,90,93.
Peripheral nerve blocks target a specific nerve branch proximally to anaesthetise its
sensory distribution distally, while periarticular infiltration works by essentially flooding
the tissue with anaesthetic and inhibiting the nerve fibres surrounding the surgical site.
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Periarticular infiltration is an easy, safe, and effective analgesic modality for the
management of post-op pain following TKA 17,103. It possesses several similar qualities
to MSNB such as maintenance of quadriceps function, promotion of early mobilization,
and reduces opioid consumption without the additional resources and cost associated
with MSNB and other peripheral blocks 12,17. The issue that arises with periarticular
infiltration is the reduced duration of analgesia, as a one-time dose of anaesthetic is
delivered at the end of the surgical procedure 81,138. In our previous study, Sogbien et al.
demonstrated that a single-injection technique with MSNB provided significantly longer
duration of analgesic effect, with a mean difference of 8.8 hours (95% CI= 3.98-13.62
hours, p<0.01) compared to periarticular infiltration 12. Previous studies have found the
duration of analgesic effect for periarticular infiltration to be variable and range
anywhere from 8 to 48 hours 81. Though effective, this method does not lend itself to
easily be transitioned to a continuous regional technique as anaesthetic distribution
needs to be diffuse to be effective. Several studies have explored the idea, utilizing a
variety of anaesthetic drug combinations, infusion rates, and procedure techniques with
variable results 81,125.
Ali et al. conducted a randomized control trial comparing intraarticular catheters in 200
patients undergoing total knee arthroplasty 110. Ropivacaine was infused intraarticularly
in the experimental group, while saline was used in the control group. Intra-operatively,
both groups received periarticular infiltration with a drug cocktail of ropivacaine,
ketorolac and epinephrine. Though not specifically stated in their paper, they were
comparing a single dose infiltration technique with a continuous intra-articular infusion.
Their primary outcome measure was VAS score for pain. The results of their study
yielded that continuous intraarticular infusion only provided a statistically significant
decrease in pain scores on post-op day one (12pm; p=0.02, 8pm p=0.03). Thus,
continuous infusion did not extend the duration of analgesia as significantly as they had
hypothesized 110.
Sun et al. performed a meta-analysis of 10 clinical trials utilizing intra-articular infusion
catheters versus placebo in 735 patients 81. Outcomes that were assessed were VAS
scores a rest and activity at 24, 48, and 72 hours post-op, duration of surgery, length of
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stay in hospital, and complications. Their resulted revealed that continuous intraarticular infusion provided statistically significant decrease in VAS pain scores at 24
hours during rest (p<0.01) and activity (p<0.01) and with activity at 48 hours (p<0.01).
There was no difference between groups in regard to pain at rest at 48 hours as well as
during rest and activity at 72 hours. The duration of surgery and the length of stay in
hospital was also similar between groups.
Similar to adductor canal blocks, high quality randomized controlled trials directly
comparing single-dose periarticular infiltration to continuous intraarticular are scarce.
Zhang et al. randomized 80 patients to three different treatment groups, single-dose
periarticular infiltration, continuous intra-articular infusion, and saline control group 138.
The primary outcome was VAS pain scores over 48 hours post-op. The analysis
revealed that VAS scores were lower in the continuous infusion group compared to the
single-dose infiltration group and were statistically significant at rest (p<0.05) from 8 to
48 hours post-op and during activity (p<0.05) from 16 to 48 hours post-op. Morphine
consumption was significantly higher in the single-dose infiltration group (p<0.05).
Maximum knee flexion at 7-and 90-days post-op was significantly increased in the
continuous infusion group as well (p<0.05) 138.
Narcotic consumption was not significantly different between our experimental and
control groups at any of the post-operative inpatient time points (p= 0.59). Periarticular
infiltration and infusion consistently required more narcotic rescue analgesia compared
to MSNB, but it was not significant (Table. 3). Our previous single- dose study
demonstrated no significant difference in opioid consumption as well, but narcotic intake
was nearly the same at all time points between groups 12. Our results reflect those
found by Beausang et al. 134. When comparing adductor canal blocks to Intra-articular
infusion, they found opioid consumption in morphine equivalents was not statistically
significant at 24 (p=0.057) and 48 hours (p=0.106) post-op between groups. Similar to
our study, they also observed that the total opioid consumption in the adductor canal
block group was less than that of the intra-articular infusion group 134.

94

Nausea is a common side effect as a result of narcotic use and was quantitatively
assessed using a 0-4 numeric scale (0=none, 1=mild, 2=moderate, 3=severe, 4=
extreme) 75. There was not a significant overall difference in nausea scores during the
6-day assessment period (p=0.21) similar to our previous study 12. Previous studies
have demonstrated that continuous analgesic methods may decrease nausea
symptoms compared to single-shot techniques or placebo 80,81,90,138. This may be due to
the prolonged analgesic quality of the continuous blocks and results in less narcotic
consumption 75.
Respiratory depression is a risk with large quantities of narcotics and so patient vitals
were collected at each post-operative timepoint to ensure there were no significant
respiratory side effects went unobserved 75. There were no statistically significant
differences in respiratory rate (p=0.54) and oxygen saturation (p=0.67) between groups
during the inpatient stay.
Post-operative function was evaluated by assessing ability to perform physiotherapy at
each time point as well as range of motion achieved. There were no significant
differences between groups in ability to perform physiotherapy (p=0.49) as well as no
differences in first flexion angle achieved (p=0.23) and best flexion angle achieved
(p=0.15) while in hospital. Again, this was similar to what Sogbein et al. observed when
no significant differences were found in patient’s eligibility to perform physiotherapy or in
time and length of first mobilization 12. When assessing range of movement between
groups, Beausang et al. also demonstrated no difference in active range of movement
between groups at any of their assessment time points 134.
Regarding our patient reported functional outcome scores, there were no significant
differences in the pre-operative and 3-month SF-12, WOMAC, or KSS outcome scores.
This is consistent with our previous study and as well as the results published by
Beausang et al. 12134. Interestingly, there was a significant difference in the KSS
expectations section of the questionnaire at the 6-week post-operative mark favoring
the MSNB group, but is unlikely to be clinically relevant and was balanced by 3-months
post-op. Our results demonstrated an improvement from pre-op scores for pain,
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stiffness, mental and physical health, and function at the 3-month mark across both
groups and was not significantly different between groups (Table 5, Table 6, Table 7).
The heterogeneity that is present across continuous peripheral nerve block and infusion
studies inevitably makes it challenging to make generalizations on complication rates
associated with these procedures, but there are some consistencies in the literature.
Largely, the risk of quadriceps weakness in adductor canal blocks is less compared to
that of other regional techniques, though it still can occur 139. In our study, one MSNB
patient and one LIA and infusion patient suffered a delay in discharge of 2 and 4 days
respectively due to quadriceps weakness. One patient in each group also suffered a
transient foot-drop that resulted in a 1-day delay in discharge each. Though we could
not find dense motor blockade as a previously described complication of periarticular
infiltration, we suspect it occurred due to inability to direct infusion flow through the
catheters and enough volume collected anteriorly and posteriorly to cause the adverse
effect. All four patients suffered only transient loss of function and were discharged once
their motor control returned.
The major concern with periarticular infusion catheters is the theoretical increased risk
of prosthetic joint infection. Several studies have reported conflicting results. A metaanalysis of seven studies (579 patients) utilizing continuous intraarticular catheter
infusions found there to be a significant increase in the rate of infection (relative risk
[RR] 3.16, 95% CI 1.18-8.50, p=0.02) when compared to placebo 81. These studies had
small sample sizes though and only three of the seven reported infection occurring in
the catheter group. A second metanalysis by Zhang et al. re-analyzed 6 of the 7 studies
in the previous analysis and reiterated these results, finding a statistically significant
difference in infection risk with intra-articular catheters (relative risk [RR} 3.45, 95% CI
1.16-10.33, p= 0.03) 125. Of the 7 studies included across both meta-analyses, only one
study was found to have a significant difference between groups in regard to infection.
Ali et al. reported a significant difference (p=0.02) between groups at 3-month post-op,
with 11 cases of infection in their intervention group (ropivacaine) and two cases in their
control group (saline). Six of these cases were deep infections (five from the
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intervention group) and all required surgical intervention. It should be noted though that
their control group also had an intra-articular catheter in situ infusing saline. The risk of
external contamination was still present, and thus they weren’t able to fully explain why
such a significant increase in infection occurred in their intervention group.
In contrast, during our assessment period there were no infections within the three
months following surgery in either group. One LIA and infusion patient developed
prolonged drainage from the site of the posterior catheter during the first two weeks
post-op but did not require intervention. Similarly, Zhang et al reported no infections at 3
months post-operatively in either of their intervention groups 138. Ham et al performed a
large retrospective-analysis of 1915 patients at a single center to determine the rate of
deep infection in patients who had received an intraarticular catheter. There was no
statistically significant difference (in the deep infection rate, with the rate in intra-articular
catheters being 0.53% as opposed to 0.77% in patients who did not receive a catheter
140

. Other randomized controlled trials have reiterated these results, finding no

statistically significant difference in infection rate with intra-articular catheters 107,109.
Interestingly, local anaesthetics have demonstrated antimicrobial effects that may help
counteract the increased risk of contamination through the intra-articular catheter 141.
Deep prosthetic joint Infection is a potentially serious complication that is unique to
intraarticular catheters. Due to the relatively short follow-up period and small sample
sizes in our own study as well as in the current prospective literature, further
investigation is needed to define the true risk of Infection 81.
Another concern involving continuous infusions is the risk of local anaesthetic systemic
toxicity. Symptoms of toxicity include circumoral numbness, metallic taste, pruritis, to
more severe complications such as cardiac arrhythmias, cardiac arrest, seizures,
respiratory arrest, and coma 89,93. One patient in the LIA and infusion group suffered
from local anaesthetic toxicity that was managed through block cessation and
supportive treatment. Due to the heterogeneity in peripheral anaesthetic drug types,
concentrations and infusion rates, no optimal infusion protocol has been identified 81,90.
Fortunately, anaesthetic toxicity is rare 80. Sites et al. performed a retrospective review
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of 12,668 patient who received ultra-sound guided nerve blocks and found the rar e to
be 1.8 per 1000 blocks performed (CI 95%, 1.1-2.7) 94. Several prospective randomized
control trials assessing both perineural catheters as well as intra-articular catheters
have also found this to be true, reporting no cases of local anaesthetic systemic toxicity
in research subjects. 107,134,135. Bleckner et al. investigated ropivacaine serum levels in
trauma patients who received long-term peripheral anaesthetic infusions at high doses
142

. The median duration of perineural catheter infusion was 7 days (range: 2-23 days)

with a median dose of 3722mg (range: 1146mg - 22,320mg). Despite the large doses
incurred by some patients, ropivacaine serum free concentrations remained below toxic
levels in all patients throughout the study and demonstrated a favorable safety profile
for these analgesic techniques 142.
A number of mild adverse events occurred during the study period that have been
previously described as potential problems with both intra-articular catheters as well as
continuous nerve blocks.80,81,89,93. These include catheter occlusion, leakage, and
dislodgement. In our trial, catheter occlusions were documented when failure to
establish patency with a saline flush occurred. There was one case of catheter
occlusion in MSNB group, where in periarticular infiltration and infusion group, 14
patients had at least one catheter occlude with blood. The reason for such a significant
difference was not unexpected, as there are three points of possible occlusion in the LIA
and infusion group and no control over the direction of infusion flow as it travels in the
path of least resistance. The haemarthrosis that forms following surgery also
predisposes the intraarticular catheter to occlusion. This may have affected the early
analgesic quality resulting in a significant difference in early rest and activity visual
analogue scores. One MSNB patient’s catheter and two LIA and infusion catheters
were accidentally dislodged from the entry sites during physiotherapy. There was one
case of significant catheter site leakage in the MSNB group and three in the LIA and
infusion group. The management for each of these was early block removal and
conversion to oral analgesia. A complication described in the literature is retained
portions of the indwelling catheter 134. No cases of catheter retention occurred
throughout the study period.
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7.1

Study strengths

The strengths of our study begin with our conservative patient eligibility criteria to
allow for as much internal and external validity in our results as possible. We strived to
have the study sample represent the real-world population as best as possible while
trying to remove some confounding variables such as pre-operative narcotic use and
chronic pain. Our study utilized randomization to reduce our risk of selection bias, as
well as control for unknown confounders. We used a single investigator to collect data
at various time points rather than multiple inpatient care providers to increase the
reliability of our data. Our experimental group utilized a unique three catheter
arrangement not previously described in the literature in an effort to provide a more
diffuse analgesic coverage comparable to MSNB. Few studies exist comparing
continuous wound infusions with other peripheral nerve blocks, and we aimed to
contribute to the current literature by comparing these two different regional anaesthetic
approaches.

7.2

Study Limitations

This randomized-control study has a number of limitations that were discovered
throughout the trial. The first limitation is the incomplete data and quoted results from
the preliminary analysis. The reasons for this are that enrollment was not completed at
the time of analysis, with 16 patients still required to reach study power, as well as the
unfortunate timing of a nationwide shortage of ropivacaine that placed the study on a
long hiatus. Thus, definitive conclusions on the primary outcome cannot be made from
the data. The study was powered to find statistically significant differences in time to
discharge from hospital. None of the secondary outcomes were factored into the power
analysis and thus no definitive conclusions of the secondary outcomes can be made
from the data upon completion. Another limitation is the small sample size, which lends
itself to more variability and the chance of the study sample not being truly
representative of the population.
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Though the study was randomized using blocked random number sequence generation,
there was a risk of selection bias occurring due to method of allocation concealment.
Random number sequence generation was performed by an independent party, but
envelop concealment was utilized for group allocation with a small blocking group of
five, opening up the possibility the investigator could anticipate assignments.
The lack of blinding in our study patients, providers, assessors and analyzers puts the
study at risk for potential biases. There was a risk of response bias due to patients
having the knowledge they are in the control or experimental group and falsely inflate or
deflate their responses for a number of reasons including their previous experience,
their personality, and their relationship with the assessor. There was also a significant
risk of performance and detection bias due to the lack of blinding of participants,
personnel, and assessors as the outcome of pain is highly likely to be influenced by
knowledge of the treatment group. Expectation bias is also a possibility with patients
expecting have a greater improvement in pain with the use an experimental treatment
(periarticular infiltration and infusion) versus standard methods. This increases the
experimental treatment response and decreases the signal detection between the two
treatment groups.
Though both treatments continuously delivered anaesthetic, there were some
unavoidable inequalities. In the MSNB group, there is less procedural variability as a
single catheter is accurately placed under ultra-sound guidance, decreasing the
likelihood of block failure. In periarticular infiltration and infusion, there are three
catheters, with one being placed posteriorly without ultrasound guidance. These
catheters had less precise placement in comparison to the MSNB and direction of
infusion flow was not controllable, taking the path of least resistance between the three
catheters. Though there was not an overall significant difference in pain scores in the
interim analysis, these discrepancies could add to the explanation as to why MSNB
demonstrated superior early analgesia at rest and with activity and are a limitation.
We did not collect blood samples to assess for serum ropivacaine levels and is a
potential limitation in our study. Though we only had one documented symptomatic
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event of anaesthetic toxicity, we are not able to comment on if other patient’s blood
levels reached toxicity and were asymptomatic with the high infusion rate (8ml/hr) and
volume we were using.
Another limitation of our study involves the data collection time points. Patients had
variable operative times on the day of surgery, and thus having fixed data collection
points (9am and 2pm on each post-operative day) meant some patients were assessed
earlier or later depending on their time of surgery. This could affect secondary outcomes
measures including pain scores, ability to perform physiotherapy, and narcotic
consumption between data collection points.
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Chapter 8

8

Conclusion
8.1

Clinical Relevance

The goal of our randomized control trial was to assess whether periarticular
infiltration and infusion has comparable clinical and functional outcomes to that of
motor-sparing nerve blocks in patients who have undergone primary total knee
arthroplasty. The use of motor sparing nerve blocks for analgesia following TKA has
been supported through our previous work as well as the existing literature. Though it is
an effective treatment, it is not a feasible option for the majority of orthopaedic surgeons
that perform knee replacements, especially in community settings. The additional skills
and cost required to provide nerve blocks consistently to patients make them difficult to
implement in a resource constrained health care system. It is our duty as a larger
tertiary center to explore continuous regional anaesthetic options that are comparable to
our standard of care and can realistically be adopted by our colleagues who don’t have
access to such analgesic options. A practical anaesthetic technique needs to be
relatively inexpensive, encourage narcotic stewardship, promotes early ambulation so
as not to delay discharge, and not have a significant increase in complications such as
infection, dense motor blockade, or a high rate of failure. Our interim analysis supports
this effort thus far by yielding non- significant results between our experimental and
control groups for our primary outcome of time-to-discharge, pain scores at rest and
activity, narcotic consumption, as well as patient reported functional outcomes.

8.2

Future direction

Our future direction for the study is to finish enrollment and the trial and continue
to explore the application of periarticular infiltration and infusion in patients undergoing
primary total knee arthroplasty. We plan to perform a retrospective review of study
patients to assess for late complications such as prosthetic joint infection that could be
associated with periarticular infiltration and infusion and determine if it is a significant
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risk. Cost effectiveness analysis is also a future plan, as we must provide evidence that
periarticular infiltration and infusion doesn’t significantly add to the overall cost of the
procedure, while being a less expensive modality than motor-sparing nerve block. We
will then explore the interest in peripheral centers for such a treatment option and assist
in its implementation into their post-operative care plans. A potential future study for
periarticular infiltration and infusion will be its roll in out-patient analgesia for same-day
or fast-tracked discharge following total knee arthroplasty by allowing patients to be
ambulatory with their regional block.
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10 Appendix B: Letter of Information and Consent

Letter of Information and Consent Form

Outcomes after Total Knee Joint Arthroplasty: A comparative study using
different analgesic techniques
Principal Investigator
Dr. James Howard

519-663-3551

Co-Investigators
Dr. Brent Lanting
Dr. Edward Vasarhelyi
Dr. Peter Mack

519-663-3335
519-663-3413

Research Assistant
Dr. James Allen
519-685-8500 x34568
Dr. Sugantha Ganapathy
Dr. Mahesh Nagappa
Dr. Deepti Vissa

You are being invited to voluntarily participate inText
a research study conducted by the Department
of Orthopedic Surgery and Departments of Anesthesiology and Perioperative Medicine at the
University of Western Ontario. As a patient scheduled to have a Total Knee Replacement (TKR),
we invite you to consider taking part in this research study. This letter of information describes
the research study and your role as a participant. Please read this letter of information carefully.
Do not hesitate to ask anything about the information provided. Your surgeon, anesthesiologist
or the study coordinator will describe the study and answer your questions. Your decision is
completely voluntary and will not affect your medical care if you choose not to participate. You
may take as much time as you need to decide whether to participate and can discuss participation
with your friends, family, family doctor, etc.
WHY ARE WE DOING THIS STUDY?
The operation you will be having (Total Knee Replacement, shortened to TKR) is a very
common one. However without proper treatment the first 2 to 3 days after the operation can be
very painful. There are several different options for providing pain relief while you are in
hospital after a TKR.
The current methods to control pain following knee surgery in our hospital include oral
medications combined with either nerve block or wound infiltration with freezing agent. A nerve
block is an anesthetic injection (freezing) targeted toward a certain nerve or group of nerves to
treat pain. The purpose of the injection is to "turn off" a pain signal coming from a specific
location in the body (in your case the knee). Ultrasound is used to help the doctor place the
needle in exactly the right location so that you can receive maximum benefit from the injection.
Sometimes, these nerve blocks can make your leg weak with a potential for you to fall down.
Performing these blocks in the mid-thigh level can minimize leg weakness while providing good
quality pain relief. Usually a tiny tube (block catheter) is placed close to the nerve carrying
sensation from the knee joint which is connected to a pump delivering freezing around the same
nerve. These nerve blocks are continued after surgery so that the surgical wound is frozen as
long as the blocks are in place. Alternately, the surgeon may insert tiny tubes around the joint at
the end of surgery to deliver freezing around the joint (called wound infiltration). These tiny
17 October 2017
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tubes are connected to a balloon pump delivering freezing directly into the wound. Along with
the nerve blocks or freezing around the joint, you are provided with oral medications for pain
relief. The pain management techniques performed as a part of the study are commonly offered
to all patients undergoing TKR.
With all these measures, a healthy individual without any major medical or surgical problems
should be able to do physiotherapy exercises with well controlled pain following the surgery. If
you can achieve the rehabilitation goals (do the physiotherapy exercises) within the first day
following surgery, you may be suitable to be sent home while continuing the same pain
management measures.
The aim of this study is to determine the effectiveness and safety of the different pain-relieving
techniques.
WHAT DOES THE STUDY INVOLVE?
If you are eligible and agree to participate in the study, you will be randomized, like the flip of a
coin, to one of the two pain treatment groups during your visit to the preadmission clinic. To
provide anesthesia during the operation you will receive a spinal anesthetic. This will numb the
entire lower half of your body for about 4 hours. The group you are randomized to will
determine the method of postoperative pain relief. Your surgical procedure will not be changed
as a result of your participation in the study.
Group 1: Patients in this group will receive what are known as ‘motor sparing nerve blocks’
before the operation. This involves numbing the 2 nerves, which supply the bulk of the
sensation to the knee. A small plastic tube will be inserted close to the nerves supplying the knee
joint combined with injecting freezing behind the knee using an ultrasound. The anesthetic
doctor will explain the details of the procedure to you. Dilute local anesthetic (freezing) is
delivered via these tubes until discharge, keeping the operated knee numb during that period.
Group 2: This group will receive freezing solution injected into the wound at the end of surgery
by the surgeon. The surgeon will leave 3 very fine tubes inside the wound just before it is closed.
During the two days after the operation very small amounts of freezing solution will be delivered
through these tubes into the wound, in order to numb the knee.
You will receive multiple oral pain killers called multimodal analgesia starting in the
preoperative period as needed according to the standard of care for University Hospital. This
will allow your pain to be managed better.
Following the operation you will be followed up closely until you are discharged from hospital.
You will be assessed on a regular basis for any pain, feelings of nausea or sedation, and how you
are progressing with your physiotherapy. All participants will be assessed for discharge criteria
by the research staff 6 hours after surgery and twice daily until discharge. If you meet the
discharge criteria and maintain it at the next evaluation, your indwelling anaesthetic tubes will be
removed, and you will be discharged home with the care orders normally given to all patients.
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The discharge criteria include satisfaction of the first four of the five criteria:
1. You should be able to take care of personal care, get in and out of bed, into and up from a
chair, on and off a toilet and to walk with proper walking aids 70 m without time limit;
ability to do five steps.
2. Free of medical or surgical complications including urinary catheterization or need for
blood transfusion
3. Acceptable pain relief (NRS ≤ 5/10) without any need for intravenous analgesics.
4. No nausea/ vomiting; generalized weakness or dizziness.
5. Knee flexion of 900 is optional but preferred.
A pain diary will be given to you before you are discharged to record your pain, the degree of
knee movement, the success of physiotherapy, any feelings of nausea or sedation, post-operative
complications, and the amount of pain killers that you have taken twice daily. You will be asked
to complete this diary for 4 days after you are discharged from hospital. You will be educated on
how to complete your post-operative pain diary before you leave the hospital. Research staff will
call you at home on days 1 and 4 after you have been discharged from hospital to answer any
questions you may have about the pain diary. This diary will be returned to the research staff at
your next appointment with your surgeon (at 2 weeks after surgery).
Reasons for delay in discharge will be collected. The research team will obtain data regarding
any complications that you may develop while you are in the hospital from the hospital chart,
and any that develop after discharge by talking to you and your surgeon at each of your standard
follow-up appointments in clinic. Any complication that you may develop will be managed as
per the standard practice at London Health Sciences Centre.
You will be asked to complete 3 questionnaires (SF-12, WOMAC and Knee Society Score) at
your preadmission appointment before surgery and at 6 weeks and 3 months after surgery. These
questionnaires ask about your general health, pain and function. At your 2 week visit to clinic,
the research staff will measure the range of motion of your knee and ask about your pain. There
are no extra visits required as part of this study. Follow-up appointments at 2 weeks, 6 weeks and
3 months are all standard of care for the surgeons involved in this study.
RISKS
Regional nerve blocks have been shown to be a very safe alternative to general anesthesia.
However, just as general anesthesia carries risks, regional anesthesia entails certain risks too.
Serious risks are very rare, but they are of a different nature to those of general anesthesia and
the risks are detailed below. The numbers below indicate the risk of each problem. For example
1/10,000 means on average 1 in every 10,000 patients undergoing a nerve block will suffer that
problem.
1. Failed block: The block may provide inadequate pain relief. This occurs in 5/100 to
10/100 of patients. If this occurs, alternative oral or intravenous medications such as
morphine or dilaudid will be used to make you comfortable.
2. Risk of suffering some degree of bruising from the needle injection site – 1/10 to 1/100.
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3. Temporary nerve irritation leading to an area of numbness or tingling persisting for up to
a week – 1/100
4. Risk of suffering a temporary seizure due to the local anesthetic being too rapidly
absorbed – very rare. 1/10,000 to 1/100,000.
5. Risk of suffering longer-term nerve damage lasting several months – very rare. 1/5000 to
1/10,000.
6. Risk of suffering permanent nerve damage – very rare – 1/100,000,000.
Side effects from the sedation include short-term (a few minutes to a few hours) drowsiness,
forgetfulness and sometimes minor temporary itching.
Wound infiltration and infusion of local anesthetic may be associated rarely with toxicity from
absorbed local anesthetic, nerve injury and infection. The exact frequency of these problems is
currently unknown.
A member of the research team will explain all the details during your visit to the preadmission
clinic.
EXPECTED DURATION OF THE STUDY AND NUMBER OF SUBJECTS EXPECTED
TO PARTICIPATE
There will be about 70 people in this study, which will be conducted at University Hospital,
London. The study is expected to run for one year; however your participation is expected to last
3 months (from surgery until your 3 month follow-up appointment).
STUDY RESTRICTIONS/PARTICIPANT RESPONSIBILITIES
As a participant in a research study, you have certain responsibilities.Your responsibilities are to:
1.
2.
3.

Follow procedures as instructed
If possible, answer the study related questions asked by the research team
Report all changes in your physical or mental condition during the course of the study,
whether or not you feel they are related to the study procedures

The study doctor has the right to stop your participation in the study at any time, with or without
your consent, if he or she feels that this is in your best interest.
The study or part of the study may be stopped at any time at the discretion of your study doctor,
or the University of Western Ontario Health Sciences Research Ethics Board.
Tell a study doctor immediately if you have a side effect from the treatment.
All female patients in the childbearing age group not practicing acceptable methods of
contraception will have a urine pregnancy test done on the morning of surgery. Subjects who test
positive for the pregnancy test will not be able to participate in the study

17 October 2017

Page 4 of 7

_______________

Participant’s Initials

125

BENEFITS
Participation in this study may or may not be of a direct benefit to you. It is possible your pain
relief may be better as you will be very closely monitored while you are in hospital.
ALTERNATIVES TO STUDY PARTICIPATION
If you decide not to participate in this study it will NOT prejudice your care. After discussion
with your anesthesiologist you will receive the most appropriate anesthetic which will suit you
the best for the procedure you are having done.
VOLUNTARY PARTICIPATION
Your participation in this study is completely voluntary. You may refuse to participate, refuse to
answer any questions or withdraw from the study at any time with NO effect on your future care.
You do not waive any legal rights by signing the consent form.
PRIVACY AND CONFIDENTIALITY
All records compiled during this study in which you are identified will be kept confidential, and
will not be disclosed outside the research group except as required by law and as described
below.
Tests and procedures done solely for this research study may be placed in your medical record to
indicate your participation in this study. Upon completion of the study, you may have access to
the research information if contained in the medical record.
Representatives of the University of Western Ontario Health Sciences Research Ethics Board
may contact you or require access to your study-related records to monitor the conduct of the
research. You do not waive any legal rights by signing the consent form. If you choose not to
sign the consent form, you will not be included in this research study. You may choose to
withdraw from the study even after consenting for the participation in the Study. If you choose
not to sign the consent form, you will not be included in this research study.
RESEARCH RELATED INJURY
If physical injury occurs due to your involvement in this research, medical treatment will be
available to you as per the standard care at our institution provided by OHIP. Compensation for
lost wages and/or direct or indirect losses is not available.
COST/COMPENSATION
There will be no additional costs to you as a result of being in this study. You will not be
compensated for participation in this study.
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CONTACT FOR QUESTIONS
Before you sign the consent form, you should ask questions about anything that you do not
understand. The study staff will answer questions before, during, and after the study.
If you have questions about this study or how it is being run, you should contact Dr. James
Howard, the principal investigator at 519-663-3551, or the research assistant, Dr. James Allen at
519-685-8500 x34568 at London Health Sciences Centre, University Hospital. If you have any
questions about your rights as a research participant you may contact the Office of Human
Research Ethics at 519-661-3036 or ethics@uwo.ca.
In case of an emergency, please contact Dr. James Howard at 519-663-3551 OR go to the nearest
hospital emergency department.
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Consent Form

Outcomes after Total Knee Joint Arthroplasty: A comparative study using
different analgesic techniques.
I have read the Letter of Information, have had the nature of the study explained to me and I
agree to participate. All questions have been answered to my satisfaction. I will receive a copy
of the Letter of Information and this signed consent form.

Print participant’s full name

Date

Participant’s signature

Name of person obtaining consent

Date

Signature of person obtaining consent
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11 Appendix C: Image use consent
From:
Subject:
Date:
To:

photiusc@gmail.com
Re: Photius.com Feedback
19 March 2019 at 06:56
James.Allen@lhsc.on.ca

Hello James Allen,
Thank you for your inquiry,
You are welcome to use the text and images, and we request that you acknowledge the source as:
"Source: theodora.com/anatomy, used with permission", and in case of online publication, that you also place a link to the site:
"Source: <a href="https://theodora.com/anatomy">theodora.com/anatomy</a>, used with permission".
Regards,
Photius Coutsoukis

OTHER ITA WEB SITES:
- Menu of ITA websites - STREET VIEWS

On Mon, Mar 18, 2019 at 9:46 PM World Wide Web Owner <www@pubweb-2.bestweb.net> wrote:
This email was received from your feedback form located at photius.com.
Name:
James Allen
r_Email:
James.Allen@lhsc.on.ca
r_Email_2:
James.Allen@lhsc.on.ca
email_subject:
Photius.com Feedback
Message:
Hello,
My name is James and I am a orthopaedic resident and current master's student at the University of Western Ontario. I am
currently writing my thesis titled "POST-OPERATIVE ANALGESIA FOLLOWING TOTAL KNEE ARTHROPLASTY: A
RANDOMISED CONTROL TRIAL COMPARING REGIONAL TECHNIQUES" and was wondering if I could kindly request the
use of your images as they are great Grey's illustrations. The list includes:
Knee joint:
Figure 345
Fig. 346
Fig. 347
Thigh cutaneous distribution:
Fig. 825
Fig. 826
Femur:
fig 244
fig 245
Popliteal artery
fig. 552
Usage would be in the lit review section and would be full credited. I really appreciate your time and I look forward to hearing
back from you.
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From:
Subject:
Date:
To:

Daryl Goldman goldmadt@gmail.com
Re: Figure use for thesis
27 March 2019 at 10:15
James Allen James.Allen@lhsc.on.ca

Hey sorry,
It is fine as long as you get permission from the publisher.
Thanks,
Daryl
On Wed, Mar 27, 2019 at 9:50 AM James Allen <James.Allen@lhsc.on.ca> wrote:
Hi Dr. Goldman,
Hope you are doing well. Any chance you have heard from your co-authors about the use of the image? I am terribly sorry for
the repeated messages and I know how busy you are. I appreciate your time!

Thanks,
Dr. James H. Allen
PGY1 Orthopaedic Surgery
Western University

From: Daryl Goldman <goldmadt@gmail.com>
Date: Thursday 21 March 2019 at 16:39
To: James Allen <James.Allen@lhsc.on.ca>
Subject: Re: Figure use for thesis
Hi James!

Let me check with the other authors.

Thanks,
Daryl

On Thu, Mar 21, 2019 at 4:38 PM James Allen <James.Allen@lhsc.on.ca> wrote:
Hello Dr. Goldman,
My name is James Allen and I am an Orthopaedic Surgery resident at Western University, Ontario and a current Masters of
Surgery student. I writing my thesis currently on the subject of post-op pain control following total knee arthroplasty. The title
is “POST-OPERATIVE ANALGESIA FOLLOWING TOTAL KNEE ARTHROPLASTY: A RANDOMISED CONTROL TRIAL
COMPARING REGIONAL TECHNIQUES”. I was wondering if it would be possible to get your approval for the use of a
figure in a recent paper of yours, “Current Concepts and Future Directions of Minimally Invasive Treatment for Knee Pain”,
specifically Figure 1 demonstrating the knee neuroanatomy as it is a fantastic image.
Its use would be in the literature review section and would be listed with a proper citation.
I appreciate the time and look forward to your reply.
Thanks,
James H. Allen

This email is directed in confidence solely to the person named above and may contain confidential,
privileged or personal health information. Please be aware that this email may also be released to
members of the public under Ontario's Freedom of Information and Protection of Privacy Act if
required. Review, distribution, or disclosure of this email by anyone other than the person(s) for whom
it was originally intended is strictly prohibited. If you are not an intended recipient, please notify the
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it was originally intended is strictly prohibited. If you are not an intended recipient, please notify the
sender immediately via a return email and destroy all copies of the original message. Thank you for
your cooperation.
-Best,
Daryl Goldman, MD
PGY1 - Department of General Surgery, Lenox Hill Hospital
Email: goldmadt@gmail.com
Cell: 720-688-8844
@Daryl_Goldman

This email is directed in confidence solely to the person named above and may contain confidential,
privileged or personal health information. Please be aware that this email may also be released to
members of the public under Ontario's Freedom of Information and Protection of Privacy Act if required.
Review, distribution, or disclosure of this email by anyone other than the person(s) for whom it was
originally intended is strictly prohibited. If you are not an intended recipient, please notify the sender
immediately via a return email and destroy all copies of the original message. Thank you for your
cooperation.
-Best,
Daryl Goldman, MD
PGY1 - Department of General Surgery, Lenox Hill Hospital
Email: goldmadt@gmail.com
Cell: 720-688-8844
@Daryl_Goldman
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From:
Subject:
Date:
To:

Oliver Jones oliver@teachmeseries.com
RE: New submission from Contact us
24 March 2019 at 07:38
jamesallen@rcsi.ie

Dear James,
Thanks for ge1ng in touch – you are more than welcome to use this image in your thesis as
described in your email.
Best wishes,
Oliver
Dr Oliver Jones
Founder - The TeachMeSeries
07432634782
oliver@teachmeseries.com

From: TeachMeAnatomy <oliver@teachmeseries.com>
Sent: 21 March 2019 20:45
To: Oliver Jones <oliver@teachmeseries.com>
Subject: New submission from Contact us
New message from teachmeanatomy.info
Name
James
Email
jamesallen@rcsi.ie
Subject
Use of photo for thesis (TIME SENSITIVE)
Message
To Whom it may concern,
My name is James Allen and I am a first year Orthopaedic Resident at UWO in Canada and a
masters student. I am writing to you with a request for permission for the use of one of your
photos, "Fig 1.0 – Cross-section of the thigh, showing the borders of the adductor canal. Note: the
adductor magnus is not visible in this illustration" on the adductor canal webpage. I am looking to
use it in the literature review section of my thesis and it will be appropriately cited.
Thanks
-James

Do not reply to this message, use the email address provided to reply to user.
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WOLTERS KLUWER HEALTH LICENSE
TERMS AND CONDITIONS
Mar 18, 2019

This Agreement between Western University -- James Allen ("You") and Wolters Kluwer
Health ("Wolters Kluwer Health") consists of your license details and the terms and
conditions provided by Wolters Kluwer Health and Copyright Clearance Center.
License Number

4552010094714

License date

Mar 18, 2019

Licensed Content Publisher

Wolters Kluwer Health

Licensed Content Publication WK Health Book
Licensed Content Title

Rockwood and Green’s: Fractures in Adults, 8e

Licensed Content Author

Court-Brown, Charles M.; Heckman, James D.

Licensed Content Date

Dec 31, 2014

Type of Use

Dissertation/Thesis

Requestor type

academic/educational

Format

print and electronic

Portion

figures/tables/illustrations

Number of
figures/tables/illustrations

2

The ID numbers of the
figures/tables/illustrations
are...

figure 52-7 figure 52-4

Will you be translating?

no

Reusing current or a
previous edition

current edition

Circulation/distribution

100

Title of your thesis /
dissertation

POST-OPERATIVE ANALGESIA FOLLOWING TOTAL KNEE
ARTHROPLASTY: A RANDOMISED CONTROL TRIAL COMPARING
REGIONAL TECHNIQUES

Expected completion date

Aug 2019

Estimated size (number of
pages)

120

Requestor Location

Western University
250 Fire Route 5

Woodview, ON K0L3E0
Canada
Attn: Western University
Total

0.00 CAD

Terms and Conditions

Wolters Kluwer Health Inc. Terms and Conditions
1. Duration of License: Permission is granted for a one time use only. Rights herein do not
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Title:

Author:

Current Concepts and Future
Directions of Minimally Invasive
Treatment for Knee Pain

Logged in as:

Daryl T. Goldman, Rachel
Piechowiak, Daniel Nissman et al

Account #:
3001422108

James Allen
Western University

Publication: Current Rheumatology Reports
Publisher:

Springer Nature

Date:

Jan 1, 2018

Copyright © 2018, Springer Science Business Media,
LLC, part of Springer Nature

Order Completed
Thank you for your order.
This Agreement between Western University -- James Allen ("You") and Springer Nature ("Springer Nature") consists of your license details and the terms and conditions
provided by Springer Nature and Copyright Clearance Center.
Your confirmation email will contain your order number for future reference.
printable details
License Number

4557101480210

License date

Mar 27, 2019

Licensed Content
Publisher

Springer Nature

Licensed Content
Publication

Current Rheumatology Reports

Licensed Content Title

Current Concepts and Future Directions of Minimally Invasive Treatment for Knee Pain

Licensed Content Author

Daryl T. Goldman, Rachel Piechowiak, Daniel Nissman et al

Licensed Content Date

Jan 1, 2018

Licensed Content Volume 20
Licensed Content Issue

9

Type of Use

Thesis/Dissertation

Requestor type

academic/university or research institute

Format

print

Portion

figures/tables/illustrations

Number of
1
figures/tables/illustrations
Will you be translating?

no

Circulation/distribution

<501

Author of this Springer
Nature content

no

Title

POST-OPERATIVE ANALGESIA FOLLOWING TOTAL KNEE ARTHROPLASTY: A RANDOMISED CONTROL TRIAL COMPARING REGIONAL TECHNIQUES

Institution name

n/a

Expected presentation
date

Aug 2019

Portions

From the following paper, "Current Concepts and Future Directions of Minimally Invasive Treatment for Knee Pain" I am hoping to use the image Fig. 1 in my thesis. Thank you

Requestor Location

Western University
250 Fire Route 5
Woodview, ON K0L3E0
Canada
Attn: Western University

Total

0.00 USD
ORDER MORE

CLOSE WINDOW

Copyright © 2019 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.
Comments? We would like to hear from you. E-mail us at customercare@copyright.com
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James Hilliard Allen Curriculum Vitae

Educational Background
Orthopaedic Surgery Resident 2018-2023, Department of Orthopaedic Surgery,
Schulich School of Medicine, Western University
MB, BCh BAO (NUI, RCSI), LRCP&SI, Royal College of Surgeons in Ireland- 2010- 2016
Six-Year Program. Graduated with Honours

Certifications and Assessments:
Advanced Trauma Life Support- June 2018
Advanced Cardiac Life Support and renewal of Basic Cardiac Life Support- June 20182020
Standard First Aid & CPR- Basic Cardiac Life Support (BCLS)- June 2018-2020

Research Experience:
Surgeon Scientist Program: Schulich School of Medicine and Dentistry- Western
University - September 2017-August 2019
MSc Degree (candidate)
Thesis title: Outcomes after Total Knee Joint Arthroplasty: A comparative study using
different analgesic techniques
Description:
• Prospective randomized control trial
• Assessing two possible local anesthetic modalities following unilateral Primary Total
Knee Arthroplasty
• Two groups include the control group, Motor Sparing Nerve block, and the intervention
group, Local Infiltration anaesthesia plus periarticular infusion.
• Collected data points include analgesic quality, side effects and complications, narcotic
consumption, and functional outcomes preoperatively and postoperatively
Required Courses:
• Advanced Principles of Surgical Research
• Advanced Surgical Research Colloquium
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•

Advanced Statistics and Research Methods for Surgeons

Head Injury in Patients with Hip Fractures: A Retrospective Review
• Data collection and second author roles
• Assessing the indications and frequency of CT head scans in the hip fracture
population
• Assessing the appropriateness of the Canadian CT Head Rules/ New Orleans
Criteria in this population
• Poster presentation at the 2018 American Academy of Orthopaedic Surgeons and
the 2018 Canadian Orthopaedic Association annual meetings
• High scoring poster award at the Canadian Orthopaedic Association annual meeting

Orthopaedic Research: Mount Sinai Hospital- University of Toronto- September
2016-December 2017
Revision Hip Arthroplasty long-term survivorship study using the Zimmer ZMR Modular
Hip System
Description:
• Retrospectively reviewed 335 patients who received a Tapered or Porous ZMR
femoral component between 1999 to 2006 at Mount Sinai Hospital
• Follow-up studies conducted to reassess the same patient groups from previous
mid-term survivorship papers from Mount Sinai published in 2010
• Reviewed Tapered and Porous groups separately to assess follow-up and
complications to determine rate of failure
• Patients were contacted if digital records were inadequate
• Harris Hip scores were obtained to determine post-operative functional outcomes
• Follow-up radiographs were classified for component osseous integration and
proximal bone stock by fellowship trained arthroplasty surgeons
• Podium Presentation at the 2018 American Academy of Orthopaedic Surgeons and
the 2018 Canadian Orthopaedic Association annual meetings
Professional Experience

Rural Orthopaedic Surgery: Cape Breton Regional Hospital- November 2016
Two-week elective with Dr. Kevin Orrell, former Canadian Orthopaedic Association
President
Description:
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•
•
•
•

Operating Room privileges with hands-on participation in 15 cases
Clinic privileges using clinical knowledge to develop management plans for various
Orthopaedic conditions
One-on-one teaching from consultant Orthopaedic surgeons
Further Rural medicine experience and understanding of the Nova Scotia
Healthcare System

Community Orthopaedic Surgery: Chatham-Kent Health Alliance- January 2016
Three-week elective with Dr. John Turnbull
Description:
• Operating Room privileges participating in approximately 30 cases
• Clinic privileges and further involvement as I was the only student
• One-on-one teaching from consultant Orthopaedic surgeons
• Full time on-call for the full elective period
• Further Rural medicine experience and understanding of the Ontario Health System

General & Orthopaedic Oncology Surgery: Dalhousie University- September 2015
Two-week elective in Halifax Infirmary with Dr. Michael Biddulph
Description:
• Clinical elective including direct patient contact in clinical settings (in and outpatients)
• Operating room privileges observing and participating in approximately 30 cases
• Attended all resident teaching sessions, on-call, and grand-rounds
• Attended weekend-call while at Halifax Infirmary assisting junior and senior
residents
• Worked alongside final-year residents, fellows, and other visiting elective medical
students in the clinics, operating room, and in-patient wards
• Further development of Orthopaedic history taking and physical exam skills as well
as obtaining more knowledge in establishing working differential diagnoses
• Further knowledge into the potential treatment options of various Orthopaedic
injuries, congenital skeletal defects, and reconstructive procedures
• Development of the communication skills required to work in a cohesive surgical
team

Arthroplasty & Trauma Orthopaedic Surgery: Schulich School of Medicine
and Dentistry- Western University - August 2015
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Three-week elective with Dr. James Howard, participated in the operating rooms of Dr.
Brent Lanting, Dr. David Sanders, as well as the out-patient clinics and operating rooms
of Dr. Edward Vasarhelyi.
Description:
• Clinical elective including direct patient contact in clinical settings (in and outpatients)
• Operating room privileges observing and participating in approximately 30 cases
• Attended all resident teaching sessions, on-call and grand-rounds
• Worked alongside final-year residents, fellows, and other visiting elective medical
students
• Further development of Orthopaedic history taking and physical exam skills as well
as obtaining more knowledge in establishing working differential diagnoses.
• Further knowledge into the potential treatment options of various Orthopaedic
injuries, congenital skeletal defects, and reconstructive procedures
• Development of the communication skills required to work in a cohesive surgical team

Orthopaedic Oncology Surgery: University of Toronto- July 2015
Two-week elective in Mount Sinai Hospital with Dr. Peter Ferguson
Description:
• Clinical elective including direct patient contact in clinical settings (in and outpatients)
• Operating room privileges observing and participating in approximately 20 cases
• Attended all resident teaching sessions, tumor board meetings with multidisciplinary team, on-call, and grand-rounds
• Worked alongside final-year residents, fellows, and other visiting elective medical
students in clinic and operating rooms
• Participated in the operating rooms and out-patient clinics of Dr. Jay Wunder
extensively during the two-week elective period
• Further development of Orthopaedic history taking and physical exam skills as well
as obtaining more knowledge in establishing working differential diagnoses
• Further knowledge into the potential treatment options of various Orthopaedic
injuries, congenital skeletal defects, and reconstructive procedures
• Development of the communication skills required to work in a cohesive surgical team

Pediatric Orthopaedic Surgery: McMaster University- July 2015
Two-week elective in McMaster University Medical Centre with Dr. Paul Missiuna
Description:
• Clinical elective including direct patient contact in clinical settings (in and out-

138

•
•
•
•
•
•
•

patients)
Operating room privileges observing and participating in approximately 15 cases
Attended all resident teaching sessions, on-call, and grand-rounds
Worked alongside final-year residents, fellows, and other visiting elective medical
students
Participated in the operating rooms and out-patient clinics of Dr. Devin Peterson, Dr.
Jung Mah, Dr. Rick Ogilvie extensively as well as participated in the clinics of Dr.
Bradley Petrisor, and Dr. Sarah Burrow
Further development of Orthopaedic history taking and physical exam skills as well
as obtaining more knowledge in establishing working differential diagnoses
Further knowledge into the potential treatment options of various Orthopaedic
injuries, congenital skeletal defects, and reconstructive procedures
Development of the communication skills required to work in a cohesive surgical team

Community Orthopaedic Surgery: Schulich School of Medicine and DentistryWestern University, SWOMEN program- June-July 2015
Two-week elective through the Southwestern Ontario Medical Education Network with
Dr. John Turnbull
Description:
• Operating Room privileges participating in approximately 25 cases
• Clinic privileges and further involvement as I was the only student
• Further Rural medicine experience and understanding of the Ontario Health System
• Extensive involvement in the operating room with Dr. John Turnbull, Dr. Hans Hundt,
Dr. Jonathan Stone, and Dr. Zaheer Kukkadi as surgical assist
• Further development of Orthopaedic history taking and physical exam skills as well
as obtaining more knowledge in establishing working differential diagnoses
• Further knowledge into the potential treatment options of various Orthopaedic
injuries, congenital skeletal defects, and reconstructive procedures
• Development of the communication skills required to work in a cohesive surgical team

Orthopaedic Research: Western University: January-March 2014
Six weeks in the Fowler Kennedy Clinic with Dr. Kevin Willits
Description:
• Completed clinically relevant retrospective review looking at bone healing with
computed tomography following medial opening wedge high tibial osteotomy
• Attended clinics at Fowler Kennedy
• Attended operating room cases relevant to the research as well as supplemental
operating room time for further experience and knowledge
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Orthopaedic Surgery Observership: Chatham-Kent Health Alliance June–August
2013
Ten weeks of Orthopaedic Surgery observership in Chatham, Ontario under Dr. Hans
Hundt.
Description:
• Participated in daily routines observing Dr. Hans Hundt and Dr. John Turnbull.
• Participated in surgical rounds for in-patients
• Took part in weekly clinics and ambulatory care
• Observed and assisted with over 140 Orthopaedic surgical cases ranging from total
joint arthroplasty to arthroscopy
• Attended on-call with Dr. Hundt
• Gained knowledge of basic pathological, physiological, and natural disease history
principles of common Orthopaedic conditions and injuries

Extracurricular Activities & Involvement

Peer-led Tutor: Royal College of Surgeons Ireland

2015-2016

Description:
• Tutorials in Orthopaedic Physical Examination.
• Small group teaching tutorials for students beginning their clinical learning.
President of the Royal College of Surgeons Orthopaedic Society: 2015-2016
Description: 400+ member society focused on increasing the interest and teaching the
basic principles of Orthopaedic surgery.
• Further development of previous events such as Orthopaedic tool representative
talks
• Development of events to engage students and peak interest in the field of
Orthopaedic Surgery
• Organization of case presentations and Journal Clubs
• Provision of peer-led teaching tutorials on Orthopaedic Physical Examination
• Provided assistance to younger students with preparation for summer Orthopaedic
electives.
• Organized and successfully completed an introduction to plaster casting event
Board Member Orthopaedic Society: Royal College of Surgeons 2014-2015
Description:
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Event coordinator responsible for planning and organization of educational and
entertaining society events for members
Provided students further knowledge into the profession of Orthopaedic Surgery
Branding development and social-media management for the society

